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ABSTRACT 
 
 
“One-dimensional” nanostructures like nanotubes and nanorods hold great potential for a 
wide variety of applications.  In particular, one-dimensional nanostructures may be able to 
provide many significant advantages over traditional spherical particles for drug delivery 
applications.  Recent studies have shown that long, filamentous particles circulate longer within 
the body than spherical particles, giving them more time to reach the target area and deliver their 
payload more efficiently.  In addition, studies investigating the diffusion of drugs through 
nanochannels have shown that the drug diffusion profiles can be controlled by varying the 
nanochannel diameter when the drug diameter and nanochannel diameter are close in size.  The 
combination of increased circulation time and controllable drug release profiles give one-
dimensional nanostructure great potential for future drug release applications.  To fully realize 
this potential, a simple, low cost, and versatile fabrication method for one-dimensional 
nanostructures needs to be developed and exploited.    
The objective of this work is to demonstrate the versatility of template-assisted 
nanofabrication methods by fabricating a variety of unique protein and polymer one-dimensional 
nanostructures.  This demonstration includes the adaptation of two different template-assisted 
methods, namely layer-by-layer assembly and template wetting, to fabricate glucose oxidase 
nanocapsules with both ends sealed, segmented polystyrene and poly(methyl methacrylate) 
nanorods, and poly(L-lactide)-poly(methyl methacrylate) core-shell nanowires with adjustable 
shell layer thicknesses.  The unique nanostructure morphologies that were achieved using our 
novel fabrication methods will open the arena for future research focused on process control and 
optimization for specific applications. 
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CHAPTER 1: INTRODUCTION 
Since the discovery of carbon nanotubes in the early 1990’s researchers have put forth a 
significant amount of effort to fabricate novel nanomaterials and to demonstrate their potential to 
revolutionize nearly all areas of research.  As we approach the end of the second nanotechnology 
driven and inspired decade, the potential of nanomaterials has not yet been fully exploited and 
the fabrication of newer, more complex, multifunctional nanostructures continues.  
Nanotechnology has and will continue to significantly impact the field of drug delivery.  
In October 2000 the US National Nanotechnology Initiative (NNI) was initiated and included 
five research and development targets related to drug development and delivery out of a total of 
twenty five [1].  These targets included [1], 
• no suffering and death from cancer when treated 
• advanced materials and manufacturing  
• pharmaceutical synthesis and delivery,  
• converging technologies from the nanoscale, and  
• life-cycle biocompatible/sustainable development.   
This thesis focuses on the “advanced materials and manufacturing” target through the 
development of nanofabrication methods to produce unique nanomaterials for drug delivery that 
are simple, low cost, and could potentially lead to large scale manufacturing. 
Nanotechnology based drug delivery devices are expected to provide a number of advantages 
over traditional drug delivery.  These advantages include enhanced drug bioavailability, 
improved timed release, precision drug targeting, reduced drug toxicity and more efficient drug 
distribution [1].  Nanotubular structures, in particular, are expected to offer many advantages 
over spherical nanoparticles for drug delivery applications.  First, the cavity inside nanotubes can 
have a considerably greater volume than a spherical particle of the same diameter and can 
therefore hold a larger drug payload [2].  This could be extremely important for targeted drug 
delivery because significantly fewer nanotubes would need to reach the target area to deliver the 
necessary drug dosage.  The second advantage of nanotubes for drug delivery is the availability 
of both the internal and external surfaces of the nanotubes for chemical modifications and added 
functionalities [2].  Lastly, it was recently discovered that nanoparticles with high aspect ratios, 
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like nanotubes and nanowires, are able to circulate longer within the body than spherical 
particles of the same diameter [3-8].  This is important for two reasons; first, it gives nanotubes 
more time to reach targeted areas within the body before they are recognized and removed by the 
body’s immune system and second, it allows nanotubes to release their payload over longer 
periods of time and would reduce the frequency at which the drug formulation would need to be 
administered to a patient. 
The potential advantages of nanotubular structures for drug delivery are very promising 
for the future. To explore these potential advantages it is necessary to develop a simple, low cost, 
and versatile fabrication method that will enable control over important nanostructure features 
including type of material(s), diameter, length, aspect ratio, nanotube wall thickness, and tube 
versus rod morphology.  A fabrication process that offers precise control of the nanostructure 
morphology and dimensions will enable researchers to optimize the design of one-dimensional 
nanostructures for specific applications, including drug delivery.  
Research Objective 
The objective of this work was to demonstrate the versatility of template-assisted 
nanofabrication to fabricate one-dimensional nanostructures with unique morphologies and 
controllable dimensions that may be useful for drug delivery applications.  
Research Plan 
The research plan for this project focused primarily on exploiting the versatility of 
template-assisted nanofabrication.  It included the fabrication of protein and polymer single and 
multi-component one-dimensional nanostructures with unique segmented and core-shell 
morphologies.  This work explored the basic principles of two template-assisted methods, 
namely the layer-by-layer method and template wetting, and investigated how the process 
variables affected the morphological outcome of the nanostructures.  
In addition, this project included the collection of preliminary experimental data for drug 
release from nanochannels.  The purpose of collecting these preliminary data was to begin 
developing an experimental procedure for loading nanochannels with drugs, estimating the 
extent of drug loading, and measuring the drug release as a function of nanochannel dimensions.  
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This experiment revealed many important issues that will be considered to modify our procedure 
for future drug release experiments. 
The research plan is given in more detail in the following outline: 
Demonstration of the versatility of template-assisted nanofabrication 
1. Fabrication of glucose oxidase nanocapsules (published in Journal of Nanoparticle 
Research): Layer-by-layer fabrication within porous anodized aluminum oxide (AAO) 
templates using covalent bonds to demonstrate glucose oxidase nanocapsules.  This 
fabrication process included a cleaving process during template dissolution to produce closed 
capsules and confirmed that the protein structures retained their biochemical activity after 
processing. 
2. Fabrication of avidin nanotubes (accepted for publication in Langmuir): Layer-by-layer 
electrostatic assembly method adapted from literature for the fabrication of single component 
avidin nanotubes within AAO templates. Despite our extensive literature review and 
experimental trials, the fabrication of avidin nanotubes was not successful.  Several 
hypotheses were drawn regarding our fabrication problems which led to the fabrication of 
glucose oxidase/avidin nanotubes by using a covalent bonding strategy in conjunction with 
electrostatic assembly.  This study revealed some significant concerns regarding the 
previously published works from which our initial fabrication method was adapted. 
3. Fabrication of bovine serum albumin nanotubes (submitted to Nanotechnology as 2nd 
author, included in appendix 1): Layer-by-layer electrostatic assembly method adapted from 
literature for the fabrication of single component bovine serum albumin nanotubes within 
AAO templates.    
4. Fabrication of segmented polystyrene-poly(methyl methacrylate) polymer nanofibers 
(published in Journal of Nanoparticle Research): Melt wetting of nanoporous AAO 
templates with multilayered thin polymer films to demonstrate heterogeneous, segmented, 
polymer nanofiber morphologies. 
5. Fabrication of core-shell poly(L-lactide)-poly(methyl methacrylate) polymer nanofibers 
(accepted for publication by Nanotechnology): Sequential solution wetting and melt wetting 
of nanoporous AAO templates to demonstrate heterogenous core-shell polymer nanofibers.  
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This study investigated the relationship between solution concentration, viscosity, and 
nanotube shell thickness and the effect of melt wetting time on the core-shell morphology. 
Preliminary investigation of drug release from one-dimensional nanostructures 
5. Drug release from polymer thin films (Submitted to the Proceedings of the MRS Fall 2008 
meeting, included in appendix 2):  Measured the release of ibuprofen from poly(L-lactide) 
thin films loaded with different initial concentrations.  The purpose of this study was to 
calculate the diffusion coefficient of ibuprofen from poly(L-lactide) for comparison with 
future release studies from nanostructures. 
6.   Preliminary measurement of drug release from nanochannels (Included in appendix 3 as 
unpublished work): Measured the release of ibuprofen from AAO templates with 200, 50, 
and 20 nm diameter pores and lengths of 60, 40, and 20 µm respectively.  The preliminary 
data revealed many important issues with our experimental procedure which will be 
considered for future drug release studies. 
Thesis Organization 
This thesis is divided into four chapters.  This introductory chapter serves to familiarize 
the reader with the motivations and goals that have driven this project.  The second chapter is a 
literature review of relevant research which has facilitated the understanding of the basic 
principles upon which this project is based.  The third chapter is a compilation of journal articles 
that have either been published or accepted for publication by peer-reviewed journals regarding 
template-assisted fabrication methods.  The formatting of the journal articles have been adapted 
for this thesis.  Finally, the fourth chapter reviews the conclusions of this project as a whole and 
provides suggestions for future work.  Included in the appendices are a description and example 
of the use of ImageJ to analyze pore size and nanostructure length, a journal article submitted to 
Nanotechnology as a second author regarding protein nanostructure fabrication, a conference 
proceedings paper detailing drug release data from polymer thin films and preliminary data for 
the release of ibuprofen from AAO templates with 200, 50, and 20 nm diameters and thicknesses 
of 60, 40, and 20 µm respectively. 
REFERENCES 
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CHAPTER 2: LITERATURE REVIEW 
Template-assisted Fabrication 
Template-assisted fabrication is an easy, low cost, and highly versatile method to 
fabricate nanostructures.  When microporous or nanoporous materials are utilized as templates, 
one-dimensional (1D) nanostructures can be fabricated by depositing a material of choice within 
the template’s nanochannels.  After deposition, the template can be selectively removed either 
partially or completely to produce a nanostructure array or freestanding 1D nanostructures 
respectively. 
Template-assisted fabrication methods can be adapted to accommodate a variety of 
different materials including metals [1-6], inorganics, semiconductors [1-6], carbon [2-7], 
polymers and proteins [1-32].  Some methods include electroless deposition[1-2,6] and 
electrochemical deposition [3,4,6] for metals, sol-gel processes[1-4,6,33,34] for inorganic and 
semiconductors, chemical vapor deposition [2,3] for carbon, in-situ polymerization [1,2,6,21] 
and template wetting [3,5-7,15-29,31,32] for polymers, and layer-by-layer deposition [1,3,8-
14,30] for proteins and polyelectrolytes.  In addition to homogeneous, single component 
nanostructures, template-assisted methods can be used to fabricate heterogeous, multi-
component, composite nanostructures [1,2,4,17,31-33].    
Nanoporous media typically used as templates for 1D nanostructure fabrication include 
track-etch membranes, which are usually made from polymers including poly(carbonate), 
poly(ethylene terephthatlate), or poly(imide) [1,3], and anodized aluminum oxide (AAO), which 
can be purchased commercially or fabricated using a well-known anodization process 
[1,3,4,6,15].  In addition to nanoporous materials, templates can also be fabricated using 
lithographic techniques.   
AAO Template Fabrication 
The use of AAO templates is especially attractive because of its simple, low cost, and 
highly controllable fabrication method.  Using the two-step anodization process to fabricate 
AAO templates allows for control of the nanochannel diameter and nanochannel length by 
varying the anodizing solution and time respectively.     
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Figure 1: Schematic illustration of the two-step anodization process used to fabricate AAO 
templates.  Scanning electron microscope images of the aluminum/alumina surface are shown for 
each step of the fabrication process. (1) The aluminum foil is electrochemically polished (2) then 
anodized to form a thick oxide layer with a non-uniform pore size distribution. (3) The 1st oxide 
layer is dissolved leaving behind a dimpled aluminum surface. (4) The aluminum is anodized a 
2nd time to form an oxide layer with a uniform pore size distribution and hexagonal pattern with 
a thickness which is proportional to the anodization time. (5) The oxide layer is separated from 
the aluminum (6) and etched to remove the barrier layer and widen the pores. 
 
In the following sections, template-assisted fabrication methods which are commonly 
used to fabricate protein and polymer nanostructures are discussed. 
One-dimensional Protein Nanostructure Fabrication: Layer-by-Layer Methods 
Protein nanostructures can be fabricated using a template-assisted method adapted from 
layer-by-layer techniques used to electrostatically assemble multilayer thin films [37,38].  Rather 
than deposit layers onto planar surfaces, layers of material are deposited onto the inner walls of 
nanopores.  This layer-by-layer deposition inside nanopores has been demonstrated using either 
chemically covalent bonds [1,9,11,30] or electrostatic attractions [3,8,10-14] to bind protein 
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layers together.  Both methods utilize the unique structural properties that are common for most 
protein molecules so they can be easily adapted to accommodate any protein.   
Covalent Crosslinking Method 
Proteins are long chains of polyamides formed by joining many amino acids together with 
peptide bonds.  Amino acids, as the name implies, contain an amino group and a carboxylic acid 
group as well as other side functional groups.  Since most proteins have at least some free amino 
groups, they can be crosslinked with molecules that contain aldehyde functionalities.  This 
enables layers of proteins to be easily bound inside nanopores by covalent bonds.  This “alternate 
immersion strategy” was originally adapted from an approach used by Hou et al to prepare 
nanotubes within AAO templates using alternating a,w-diorganophosphonate/Zr(IV) chemistry 
[35].  To make protein nanotubes, Hou et al pretreated AAO templates first with 3-amino 
propylphosphonic acid (APA) to functionalize the nanopore walls with amino groups, then with 
glutaraldehyde (GA), a difunctional aldehyde, which binds with the amino groups on the 
nanopore walls and leaves a free aldehyde group for protein binding [1,9].  Protein solutions 
were then vacuum filtered through the nanopores and immobilized on the inner walls by 
alternating protein and GA.  This layer-by-layer strategy has been used to demonstrate glucose 
oxidase [1,9,30] and hemoglobin nanostructures [1,9] and cytochrome c (cyto-c) nanotubes  [11].  
Although this crosslinking method has proven to be a versatile approach for protein 
nanotube fabrication, the use of GA and other aldehyde crosslinkers may introduce cytotoxcity 
problems.  GA has been used for the past 25 years for many biomedical applications including 
bioprostheses, immobilization of enzymes, and crosslinking of proteins and polysaccharides for 
controlled drug delivery [36].  More specifically, GA has been used to crosslink albumin, bovine 
casein, gelatin, chitosan, and poly(vinyl alcohol) to fabricate microspheres for drug delivery 
applications  [36].  Despite the widespread use of GA for biomedical applications, there are 
many studies regarding the toxicity and adverse effects of GA which yield conflicting results and 
suggest that the toxicity is primarily concentration dependent [36].  Based on the toxicity studies, 
there is a chance that GA could be used without causing any problems.  However, it is desirable 
to develop an alternative method to bind layers of proteins within nanochannels to avoid the 
potential controversy and additional precautions associated with the use of GA.           
Electrostatic Attractions Method 
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The bi-functional nature of amino acids makes them amphoteric, which means they can 
react as either an acid or a base depending upon the conditions.  In acid solutions, an amino acid 
acts as a base and is protonated, making it a cation.  In basic solutions, an amino acid acts as an 
acid and is deprotonated, making it an anion.  There is a certain pH value for all amino acids 
where there is a balance between the cationic and anionic forms.  This pH is known as the amino 
acid’s isoelectric point.  At this point the amino acid has a neutral charge. Proteins are long 
chains of polyamides formed by bonding many different amino acids together and they too have 
an isoelectric point.  The isoelectric point for proteins is essentially the pH value at which the 
charge of all the side functional groups of the amino acids within the protein is balanced, giving 
the protein a net neutral charge.  Therefore, proteins can have a net positive or net negative 
charge if the solution pH is below or above the protein’s isoelectric point respectively.  This is 
the basic principle behind the layer-by-layer build up of electrostatically bound materials. 
The use of electrostatic layer-by-layer assembly for multilayer thin films was introduced 
in 1991 by Decher [37,38].  Since its introduction it has become widely popular because of the 
simple and inexpensive nature of the process [14].  The pioneering studies that investigated the 
electrostatic layer-by-layer assembly process focused mostly on full polyelectrolytes, such as 
polystyrenesulfonic acid (PSS) and polyallylamine hydrochloride (PAH) and determined that the 
thickness of the films was influenced primary by the ionic strength of the solutions [39].  
Although researchers were able to gain control of the thickness to the molecular level using full 
polyelectrolytes and varying the ionic strength, the process was severely limited by the solubility 
of the polyelectrolytes, which decreased with increasing ionic strength [39].  To avoid this 
limitation, researchers began experimenting with weak polyelectrolytes, in which the charge, as 
described above, is strongly influenced by solution pH [39].   
The success of layer-by-layer electrostatic assembly of thin films using full and weak 
polyelectrolytes has led to the more recent advancements of forming multilayer films on 
colloidal particles followed by the dissolution of the original colloidal particle to form hollow 
capsules [14,40] or to encapsulate drug microcrystals [40], and within the pores of nanoporous 
templates to form nanotubes [3,8,10-14].   Although this method is discussed as being a 
fabrication technique for protein nanostructures, polyelectrolytes and other charged materials can 
be used as well.  Nanotubes that have been fabricated using the electrostatic layer-by-layer 
method typically include different materials acting as the cation and the anion.  Some examples 
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include alternating PAH/PSS [8], L-α-dimyristoylphosphatidic acid (DMPA)/human serum 
albumin (HSA) [10], cyto-c/PSS [11], poly lactic acid (PLA)/HSA [12], PAH/HSA [12], 
alginate/chitosan [13], and poly(acrylic acid)/PAH with Au nanoparticles [3].  Few researchers 
have demonstrated the ability to fabricate single component nanotubes with human serum 
albumim (HAS) using the electrostatic layer-by-layer assembly method [10,12].  The fabrication 
of single component nanotubes relies on the ability of a protein to act as both a cation or an anion 
depending upon the solution pH.  Although some results have been published to demonstrate the 
feasibility of this method [10,12], it has not yet been fully explored.  
One-dimensional Polymer Nanostructure Fabrication: Template Wetting Methods 
Template wetting is a process governed by the basic principles of surface wettibility or 
capillarity.  Wetting occurs when a low-energy liquid, like a polymer melt or solution, spreads 
partially or completely over the surface of a high-energy solid substrate, like glass, metal, or 
metal oxide.  The wetting of the solid surface can be characterized by the spreading coefficient, 
S, which is a measure of the interfacial energy differences between solid substrates, gases and 
liquids.  S is given by [15,19],  
S = γ SG − γ SL − γ       (1)   
where γSG, γSL, and γ are the solid-gas, solid-liquid, and liquid-gas interfacial tensions 
respectively.  When the wetting coefficient is greater than or equal to zero, complete wetting 
occurs.  Complete wetting is when a liquid spontaneously forms a thin film over the entire 
surface of a solid substrate on a very short time scale [19].  When the wetting coefficient is less 
than zero, partial wetting occurs.  Partial wetting is when a liquid partially spreads over the 
surface of a solid substrate, but eventually reaches an equilibrium shape with a finite contact 
angle [19].  
Wetting of Nanoporous Templates 
Nanoporous materials can be wet like planar surfaces.  This is of particular interest 
because, when nanoporous templates are wet with polymers, which can be either polymer melts 
[6,15,18-23,25-29,31,32] or polymer solutions [6,15-18,21,22,24,26-28,32], polymer nanotubes 
or nanorods can be formed within the template.  When a polymer melt or solution comes into 
contact with a nanoporous material, the polymer wets the nanochannels either completely or 
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partially, similar to a planar surface.  Complete wetting within a nanochannel yields a nanotube 
morphology, while partial wetting within a nanochannel yields a nanorod morphology [19].  The 
driving force for wetting a nanoporous material is heavily dependent on the interfacial tension of 
the polymer melt or solution and the nanopore radius.  The driving force, p, is given by [41] 
p =
2(γ SG − γ SL )cosθ
R
     (2)   
where R is the hydraulic radius, which can be approximated as half the radius of the nanopores.  
The interfacial tension of a polymer melt is strongly dependent upon temperature [42], allowing 
the wetting process to be controlled by varying the wetting temperature.  Therefore, by heating a 
polymer to a temperature far above its glass transition temperature (amorphous polymers) or 
melting temperature (semi-crystalline polymers), the driving force is high and nanotubes are 
formed within the nanopores on a short time scale (seconds to minutes).  This is the complete 
wetting regime.  By heating a polymer to a temperature only slightly above the glass transition or 
melting temperature, the driving force is low and nanorods are formed within the nanopores on a 
much longer time scale (hours to days).  This is the partial wetting regime.  For each polymer 
there is a temperature between the glass transition or melting temperature and the decomposition 
temperature where the wetting regime transitions from partial to complete.  This temperature is 
referred to as the wetting transition temperature, TW [19].  TW can be determined for a given 
polymer by analyzing the nanostructure morphology formed over a range of temperatures.   
 The length of nanorods formed by wetting a nanoporous template with a polymer melt in 
the partial wetting regime can be controlled by monitoring the wetting time.  The time required 
to achieve a particular length can be approximated by the rate of flow of polymer melts within 
nanopores, which has been estimated by [19,43], 
dz
dt
=
Rγ cosθc
4ηz
     (3) 
where t is the time, z the distance the polymer has traveled through the nanochannel, η the 
viscosity of the polymer melt or solution, and R the hydraulic radius.  For melt wetting the 
polymer viscosity can controlled by varying the temperature of the melt and for solution wetting 
the viscosity can controlled by changing the solution concentration.   
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Although some control over nanostructure morphology can be achieved by simply 
controlling wetting temperature and time for polymer melts, other variables more specific to the 
polymer can affect the outcome as well.  The molecular weight of the polymer, for example, can 
have a significant effect on the formation of nanotubes versus nanorods.  It has been 
demonstrated that polymer melts with low molecular weight typically yield nanorods while high 
molecular weight yield nanotubes [6,16,18].  Researchers expect solution wetting to offer more 
control over the nanostructure morphology than melt wetting because there are more variables 
that can be adjusted, which include choice of solvent, concentration of polymer, and molecular 
weight [16].   
Investigations into the controllability of both the melt wetting and solution wetting 
processes are just beginning and much work is needed to fully understand the relationship 
between the process and materials properties and the resulting nanostructure morphology.   
Nanostructures for Drug Delivery 
The Advantages of One-dimensional Nanostructures 
One of the most important design considerations for drug delivery vehicles is making 
sure that the vehicles can circulate in the blood stream for long periods of time.  The body’s 
natural immune response is a significant barrier in this respect.  When macrophage cells 
encounter foreign micro-scale particles (1µm and up) they are immediately recognized and 
internalized by the cells in a process known as phagocytosis [44].  This process prevents the 
successful delivery of the therapeutic drug to the desired location.  Macrophage cells can 
encounter and internalize foreign particles regardless of delivery method (injection, transdermal, 
or inhalation) [44]. 
Many recent studies have focused on developing strategies to prohibit phagocytosis from 
occurring [44-50].  Before particle modifications were even considered a possible approach to 
avoid phagocytosis, researchers would essentially “trick” macrophages by administering large 
doses of placebo particles to overwhelm and impair their phagocytic capacity [45-46].  After the 
placebo doses, the therapeutic particles were administered and would circulate for longer periods 
of time.  Researchers have since developed more advanced techniques to “trick” macrophages.  
These include modifications to the actual particles and include three main strategies; 
modification of surface chemistry, size, and shape.  Surface chemistry and size were the most 
 13 
important considerations until very recently.  The surface chemistry of spherical particles was 
often modified with hydrophilic polymers to prevent or slow the process of opsonization [44-46].  
Opsonization is the binding of proteins to the surface of foreign particles to increase the 
recognition and receptor specific attachment of macrophage cells [44-46].  Previous conclusions 
regarding size were based solely upon experiments with spherical particles.  It was determined 
that macrophages would internalize particles greater than 1-5 µm [44,47].  Thus, it was thought 
that nano-scale particles could simply evade phagocytosis and provide long-lasting circulation.  
Recently researchers realized that size is more than just the particle radius, but also includes 
surface area, volume, and the ratio of the surface area to volume.  These parameters describe 
more than just particle size, but also particle shape.   
It has been shown that long, cylindrical particles circulate much longer than spherical 
particles [44,47-50].  In particular, researchers at the University of Pennsylvania demonstrated 
that long polymeric filomicelles that were 22 – 60 nm in diameter and 2 – 8 µm in length 
circulated 10 times longer than spherical particles [48,48].  Additionally these researchers 
showed that the optimum length for circulation was 8 µm.  Longer particles were rapidly 
fragmented and did not show any improved circulation beyond what was achieved by particles 
there were 8 µm long [48].  These results have contributed significantly to the understanding of 
the phagocytosis of foreign particles.  Unfortunately drug delivery studies involving particle 
shape are limited by existing methods to fabricate non-spherical nanoparticles.  Therefore, there 
is a great need to research and develop simple, low cost, fabrication methods for long, filament-
like, one-dimensional nanoparticles, like the template-assisted methods discussed previously. 
Hindered Diffusion from Cylinders   
In addition to increased circulation time, one-dimensional nanoparticles are also expected 
to enable researchers to control the drug release of thereputic molecules from the inner cavity of 
nanotubular structures by varying the particle diameter.  This hypothesis is based on the theory 
of hindered diffusion.   
The diffusion coefficient of a spherical solute molecule in bulk solution can be 
approximated by the Stokes-Einstein equation which is given by,  
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where D∞ is the bulk diffusion coefficient (cm
2/s), kB is Boltzmann’s constant (1.38x10
-23 J/K), T 
is absolute temperature (K), µ is the solvent viscosity, and rs is the radius of the solute (cm).  
When a solute molecule is restricted to a cylindrical pore and the pore size is comparable to the 
solute size, the effective diffusion coefficient is typically less than the bulk diffusion coefficient.  
This situation is referred to as hindered diffusion [51,52].  The lower diffusivity of a spherical 
solute in a cylindrical pore is attributed to a thermodynamic phenomenon, where interactions 
between the solute and pore wall exclude the solute from being in the region near the pore wall, 
and a transport phenomenon, where the proximity of the pore wall causes the solute to 
experience a greater hydrodynamic drag [51,52].  Based upon these phenomena and 
experimental data, researchers have developed empirical equations to approximate the effective 
diffusion coefficient as a function of the ratio of the solute radius to pore radius (λ = rs/rp) 
[51,52].  As approximated by Renkin, the effective diffusion coefficient is given by [51,52],  
   ( ) ( )532 948.0089.2104.211 λλλλ −+−−= ∞DD    (5)    
Generally, predictions based on Eq. 5 correspond well with experimental data for rigid and 
spherical solutes. Using Eq. 5 to estimate the effective diffusion coefficient for a drug in a 
nanochannel will enable researchers to interpret their data and develop models to describe the 
drug release from nanochannels.  It can also be used to approximate the size of the nanochannel 
that will be necessary to effectively hinder the diffusion and provide additional control over the 
release profile. 
 In summary, template-assisted fabrication methods are just beginning to be explored as 
simple and low cost fabrication methods for one-dimensional nanoparticles.  Many researchers 
have begun to demonstrate the potential of both covalent and electrostatic layer-by-layer 
assembly methods to fabricate protein nanostructures and template wetting methods to fabricate 
polymer nanostructures.  There is a need to expand upon these pioneering efforts to exploit the 
versatility of these methods and demonstrate the fabrication of unique, multifunctional 
nanostructures that offer potential for specific applications.  In particular, drug delivery 
applications could potentially be improved by utilizing unique one-dimensional nanoparticles to 
achieve longer circulation times within the body and more controllable drug release profiles.   
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ABSTRACT 
Bionanomaterials have recently begun to spark a great amount of interest and could 
potentially revolutionize biomedical research.  Nanoparticles, nanocapsules, and nanotubular 
structures are becoming attractive options in drug and gene delivery.  The size of the delivery 
vehicles greatly impacts cellular uptake and makes it highly desirable to precisely control the 
diameter and length of nanocarriers to make uniform nanoparticles at low cost.  Carbon 
nanotubes have shown great potential within the field of drug and gene delivery.  However, their 
insolubility and cytotoxicity could severely delay FDA approval.  A desirable alternative would 
be to fabricate nanostructures from biomaterials such as proteins, peptides or liposomes, which 
are already FDA approved. 
In this paper we demonstrate the preparation of protein nanocapsules with both ends 
sealed using a template-assisted alternate immersion method combined with controlled cleaving.  
Glucose oxidase  nanocapsules with controllable diameter, wall thickness, and length were 
fabricated and characterized with SEM and TEM.  The biochemical activity of glucose oxidase 
in the form of nanocapsules after processing was confirmed using UV spectrometry.  Our future 
work will explore proteins suitable for drug encapsulation and cellular uptake and will focus on 
optimizing the cleaving process to gain precise control over the length of the nanocapsules. 
INTRODUCTION 
Bionanomaterials have recently begun to attract a great amount of interest and could 
potentially revolutionize biomedical research.  In particular, nanoparticles, nanocapsules and 
nanotubular structures are becoming attractive options in drug delivery and gene therapy 
research.   
Currently viral vectors are the most effective vector in cellular delivery.  However, severe 
side effects and major practical limitations, such as immune response and difficulties in scaling 
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up production, impair successful application of viral vectors.  There is great interest in exploring 
non-viral technologies to eliminate the inherent immunogenicity concerns and improve the in 
vivo efficiency.  Non-viral carriers, such as organic and inorganic nanomaterials, including 
calcium phosphate nanoparticles, carbon nanotubes, silicon oxide nanoparticles, iron oxide 
nanoparticle, lipid and polymer nanostructures, have been shown to enhance the protein uptake 
and increase the transfer efficiency of proteins or DNA across the cell membrane [1-6].  
The mechanism of enhanced cell uptake of nanocarriers has not yet been confirmed and 
remains a topic for debate.  Many virus-like particles as well as common viruses have a size 
range of 30 – 200 nm [7].  Particles could potentially be taken up by cells by paracellular 
passage, which requires sizes less than 50 nm, lymphatic uptake, which is typically for larger 
particles [8], or endocytosis, which facilitates uptake of particles between the two extremes.  
Most studies regarding CNTs and other nanoparticle systems have suggested an endocytosis 
mechanism to be responsible for cellular uptake.  Mathematical modeling simulations have 
shown that there is a critical radius for optimum cellular uptake via endocytosis for both 
cylindrical and spherical particles [9, 10].  Decuzzi and Ferrari gave a critical radius of 
approximately 14 nm and 28 nm for cylindrical and spherical particles respectively [10].  In 
addition to a critical value, both maximum and minimum values were calculated [10].  When the 
radius is below the minimum value, 12 nm and 24 nm for cylindrical and spherical particles 
respectively, there is not enough ligand-receptor binding at the cell surface to initiate the 
endocytosis process.  Likewise, when the radius is too large, greater than 320 nm and 1,600 nm 
for cylindrical and spherical particles respectively, the cell surface area is not large enough to 
wrap around the particle.  In addition, when particles are larger than 200 nm diameter they are 
easily recognized by the reticuloendothelial system which is responsible for eliminating foreign 
particles from circulation [11].  It was reported that the opsonization process, which involves 
protein adsorption on particle surfaces and the subsequent recognition and elimination of such 
coated particles from circulation, decreased when the particle size decreased from 800 nm to 
200nm, and further enhancement was observed with a particle size below 200 nm [12].  It was 
also described, however, that particle size below 100 nm led to a hepatic accumulation instead of 
long circulation which led to decreased cellular uptake [13].  As a result of the size effect,  it is 
highly desirable to be able to precisely control the diameter and length of nanocarriers and to 
establish processing conditions for producing uniform nanoparticles efficiently and at low cost.    
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Recently carbon nanotubes have attracted great interest as vaccine delivery systems, 
DNA and RNA nanovectors, or protein transporters [14-17].  Studies have shown that carbon 
nanotubes (CNTs) are able to pass through cell membranes and enter cell nuclei, potentially 
enabling them to deliver DNA [18-20].  One study showed the successful delivery of the green 
fluorescence protein gene into cultured human cells through the use of amino-functionalized 
multi-walled CNTs [19]. 
For these biomedical applications, CNTs must be functionalized with proteins, enzymes, 
or other biomaterials to enhance the solubility, biocompatibility, and biochemical functionality.  
Despite the improvements of functionalized CNTs over un-functionalized CNTs, a major 
concern of CNT based biomedical technologies is the ongoing controversy surrounding their 
cytotoxicity.  Some studies have shown that CNTs decreased keratinocyte [21], glial [22], and 
HEK293 cell survival significantly [23] and that single-walled CNTs block potassium channel 
activities when applied externally to the cell surface [24].  Others have shown CNTs to interact 
with and affect living systems without any adverse affects [19, 20, 25].  Pantarotto et al. have 
shown that ammonium functionalized CNTs have low cytotoxicity and the ability to delivery 
plasmid DNA to cells with a gene expression level 10 times greater than plasmid DNA alone 
[25].  Despite these discrepancies, CNTs have yielded very promising results for many 
biomedical applications and have led to an increased interest in fabricating nanotubes from 
purely biological materials such as proteins, peptides and liposomes.   
Protein based nanotubular structures may be very promising since they are biodegradable, 
provide high drug loading capacity, minimal tissue irritation and toxic effect, and are relatively 
easy to prepare.  There are two preparation approaches, namely self-assembly and template-
assisted synthesis for producing nanotubes directly from proteins, polymers or lipids.  The self-
assembly of biomolecules to form nanotubular structures has been studied for more than a 
decade.  Many different self-assembly mechanisms have been investigated and are typically 
unique to the chemistry and functionality of certain biomolecules [26-31].  For instance, studies 
have shown that amphiphilic phospholipids self-assemble by chiral interactions [26] and type IV 
pilin, a globular protein, self-assembles by a hydrophobe initiated conformational shift [27].  
More recently, researchers have utilized a β-sheet forming peptide to form biotinylated peptide 
nanotubes that can be decorated with proteins to achieve the desired functionality [28].  In 
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addition to β-sheet forming peptides, ring-shaped cyclic peptides have been designed to interact 
through extensive hydrogen bonding to form nanotube structures [30].  The functionality of these 
self-assembled cyclic peptide nanostructures can be varied through surface-initiated atom 
transfer radical polymerization to functionalize the surface with polymers such as N-
Isopropylacrylamide [31].  In all these cases, the morphology and dimensions of the self-
assembled nano-tubular structures are restricted by the properties of the original bulk material.  
This greatly limits the versatility of these fabrication methods.  The template-assisted methods, 
however, are highly versatile, easy processes that rely upon either the chemical crosslinking of 
proteins, which enables the so-called alternate immersion method [32, 33], or electrostatic 
charges between protein layers, which enables the so-called layer-by-layer method [34, 35].  
These template-assisted synthesis techniques incorporate concepts that can be easily adapted to 
almost any protein with little to no modifications.  This is a huge advantage of template-assisted 
approaches and makes them viable for a wide range of applications.    
Employing template-assisted approaches, a couple of previous studies have fabricated 
protein nanotubes within commercially available anodized aluminum oxide (AAO) membranes 
with 200 nm diameter pores [32-34].  Both the diameters and lengths of those protein nanotubes 
matched that of the original AAO templates.  It was also observed that the liberated protein 
nanotubes were open on both ends.  For certain applications, such as drug delivery and gene 
therapy, it is desirable to have a protein nanostructure capable of encapsulating drug molecules, 
RNA, or DNA within the protein shell. It is also desirable to be able to control both the diameter 
and the length of the fabricated protein nanostructures. 
In this paper, we demonstrate the preparation of protein nanocapsules with both ends 
sealed using a template-assisted alternate immersion method combined with controlled cleaving.  
Glucose oxidase (GOx) nanocapsules were successfully fabricated using AAO templates through 
alternate immersion in protein and cross-linking solutions.   Proteins were immobilized on the 
inner walls of the nanochannels of the AAO templates.  Protein nanocapsules with ends sealed 
were formed and liberated into solution through a subsequent cleaving process during the 
dissolution of the AAO template.   The overall fabrication procedure is shown schematically in 
Figure 1. 
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Figure 1:  Schematic of the protein nanotube fabrication process: 1. Al is anodized to produce a 
porous Al oxide layer.  2. The Al oxide layer is separated from the Al and etched to remove the 
barrier layer.  3. The free standing Al oxide is treated with binding agents. 4. The Al oxide is 
then loaded with proteins by vacuum filtration. 5. The Al oxide is dissolved to yield liberated 
protein nanotubes. 
MATERIALS AND METHODS 
Aluminum oxide template fabrication  
AAO templates with nanopore arrays with diameters in the range of 20 to 100 nm were 
fabricated in our lab using a well established two-step anodization process.  Details of the 
anodization process are published elsewhere [36].  Following anodization, the AAO was 
separated from the aluminum in a 1% mercury chloride solution. The free-standing AAO 
templates were then etched with a 0.5 M phosphoric acid solution for 30 minutes to remove the 
barrier layer and to obtain a nanoporous channel with both ends open in the AAO template.  
During this wet-etching process the nanopores were widened slightly.  For example, for 
nanopores with 20 and 50 nm diameter immediately after anodization, average pore diameters of 
32±2 nm and 67±6 nm were achieved according to scanning electron microscopy (SEM) 
characterization.  In general, the nanopore size can be controlled to a certain extent by varying 
the anodization conditions, the wet-etching solution concentration, and the wet-etching time.  In 
addition to the AAO templates fabricated in our lab, commercial Anodisc AAO membranes with 
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200 nm diameter pores and a thickness of approximately 60 µm were purchased from SPI 
supplies and used as-received. 
Protein nanotube fabrication 
Protein nanotubes were fabricated within templates with 20 to 200 nm diameter pores 
using the alternate immersion method adapted from reference [32].  Briefly, both sides of the 
AAO templates were first coated with thin (~5nm) layers of gold using an e-beam evaporator to 
prevent protein absorption to the top and bottom surfaces of the templates. The base pressure 
during the e-beam evaporation was controlled to be between 4 – 5x10-7 torr.  The optimized 
evaporation rate of 1 Å/s yielded good coating uniformity. The gold coated AAO templates were 
then immersed in a 5 mM solution of 3-amino propylphosphonic acid (APA) at pH 5.8 for 24 
hrs.  After rinsing with phosphate buffer solution (PBS) (pH 7.0), the templates were immersed 
in a solution of 2.5% glutaraldehyde (GA) in PBS for 12 hrs.  10 mL of a 10 mg/mL GOx 
solution was then vacuum filtered slowly through the template using a Millipore mini-vacuum 
system.  For additional layers, the templates were then immersed again in a 0.025% GA solution 
for 12 hrs followed by the filtration of GOx solution.  This immersion-filtration procedure was 
repeated until the desired number of protein layers was achieved.   
Protein nanotube liberation 
The GOx coated AAO templates were immersed in 100 mL of a 0.01 M hydrochloric 
acid (HCl) solution at room temperature to remove the template and liberate the protein 
nanostructures.  Complete template dissolution took between 24 – 48 hrs depending upon size 
and thickness of the AAO template. 
During the dissolution process, the exposed portion of the protein nanotubes was cleaved 
periodically from the template and released to the solution by swirling to form protein 
nanocapsules.  
After the AAO template had been completely removed, the HCl solution was filtered 
with a 0.05 µm polycarbonate nanopore membrane to collect the liberated nanocapsules.   
Protein nanostructure characterization and biochemical activity assay 
To confirm that the GOx nanotubes retained their biochemical activity in the form of 
nanocapsules after all the processing, a well-known aminophenazone/peroxidase colorimetric 
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assay [37] was performed for both template bound proteins and liberated protein nanostructures.  
For template bound proteins, the templates with various protein layer coatings were immersed in 
a solution containing 13 mM phenol, 0.7mM 4-aminophenazone, 0.1M glucose, and 10 units of 
peroxidase in PBS.  For the liberated nanocapsules, immediately after they were collected on the 
polycarbonate nanopore membrane, the whole membrane was immersed in the same amount of 
the assay solution as described above.  In both cases the templates and filters were incubated in 
the assay solution for 5 min at 37oC.  After incubation, 3 mL of solution was transferred to a 
cuvette and the absorbance was measured at 515 nm using a UV-visible spectrophometric system 
over a duration of 5 minutes.  
SEM and TEM analysis 
To confirm that GOx layers were immobilized within the nanopore channels of AAO 
templates, SEM top views of the AAO template after the immobilization of various protein 
layers were obtained using a Zeiss 982 SEM.  The liberated GOx nanocapsule length, wall 
thickness, and morphology were characterized using a JEOL 2100 TEM. 
RESULTS AND DISCUSSION 
AAO template 
 SEM images of a typical AAO template fabricated using the two-step anodization process 
in our lab and a commercial Anodisc AAO template are shown in Figure 2.    
 
Figure 2:  SEM images of a.) highly ordered, uniform, AAO nanopore array fabricated in our lab 
with 65 nm diameter pores and b.) commercial Anodisc AAO nanopore array with 200 nm 
diameter pores. 
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The image of our AAO template was taken on a hexagonal nanopore array with 65 nm diameter.  
It clearly illustrates the narrow pore size distribution and the uniform shape of the nanopores.  
These characteristics are particularly beneficial for the fabrication of uniform protein or polymer 
nanotubes. By adjusting the anodization conditions, the size and spacing of the nanopores can be 
conveniently adjusted over the range of 20 ~ 300 nm. This property provides the advantage of 
easily creating nanotubes with controlled size just by controlling the property of the AAO 
template.    
Protein nanotubes in AAO templates 
In addition to the control over the outer diameter of the protein nanotubes, another 
advantage of the template-assisted approach is the easy control over the wall thickness of protein 
nanotubes.  The inner walls of nanopores in AAO templates can be coated with single and 
multiple protein layers.  Figure 3 shows SEM top view images of an AAO template with 100 nm 
diameter nanopores coated with 1, 3, and 4 protein layers.   
 
Figure 3:  SEM images of glucose oxidase loaded AAO templates with a.) 1 protein layer b.) 3 
protein layers and c.) 4 protein layers.  A schematic illustration of the glucose oxidase protein 
dimensions is also given. Scale bars are 200 nm. 
 
It can be seen that the pore openings decrease by approximately 10 nm per protein layer coating.  
Considering the dimensions of the glucose oxidase molecule, shown schematically in Figure 3, it 
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is considered that the decrease in pore diameter corresponded well with the size of the protein 
molecule.  This observation strongly indicates that glucose oxidase was successfully 
immobilized on the inner walls of the nanopores. 
Protein nano-capsules 
TEM was employed to examine the overall morphology of the protein nanotubes.  TEM 
images revealed that after liberation the nanotubes formed within the nanopore templates became 
short, sealed nanocapsules. It was observed that the ends of the nanotubes were sealed, as shown 
in Figure 4, giving them a nanocapsule-like structure.   
 
Figure 4:  TEM image showing that the nanotubes formed within the nanopore templates became 
short, sealed nanocapsules after liberation. 
 
In the previous studies, liberated protein nanotubes with length of tens of micrometers, which 
was the same length as the template thickness, were formed.  In our study, through controlled 
swirling during the dissolution process, the shear forces cleaved the nanotubes to form 
nanocapsules and also sealed them as a result of the poor mechanical stability of the unsupported 
tips of the exposed protein nanotubes.  As confirmed by the TEM observations we were able to 
fabricate nanocapsules with lengths that were fractions of the template thickness. Figure 5 shows 
two different protein nanotubes formed within templates of the same thickness that were cleaved 
to be approximately 600 nm in one case and 1 µm in another.   
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Figure 5:  TEM images of protein nanocapsules formed within 80 nm diameter nanopore 
templates.  The lengths of the nanotubes were controlled to be approximately 600 nm on the left 
and 1 µm on the right. 
 
The process of cleaving provides us with unique control over the length in addition to the control 
over the diameter and wall thickness of the protein nanostructures. Those short protein 
nanocapsules could potentially offer great potential for drug delivery and gene therapy 
applications.   
To demonstrate the versatility of this template assisted method, we created Y-shaped 
protein nanocapsules.  Starting with AAO templates with Y-shaped nanochannels, as shown 
schematically in Figure 6, 1 layer of GOx was immobilized to the inner walls of the 
nanochannels.   
 
Figure 6: TEM images of branched protein nanocapsules fabricated from Y-shaped nanochannel 
arrays. 
 
The overall processing is similar to the synthesis of straight protein nanocapsules. The resulting 
protein nanostructures maintained the shape of the template, yielding Y-shaped or branched 
protein nanotubes.  The formation of Y-shaped protein nanocapsules strongly illustrates the 
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unique capability of template-assisted fabrication to provide control over the shape and size of 
protein nanostructures. 
Bio-chemical activity of protein nanostructures 
To confirm that the enzymatic activity of the GOx molecules had not been sacrificed after 
the multiple processing steps, the ability of the GOx to catalyze the decomposition of glucose to 
gluconic acid was measured using UV-vis spectroscopy.  The catalytic activity was measured 
both before and after template dissolution.  Figure 7 compares the enzymatic activities of one 
layer GOx bounded in nanochannels with 32 nm diameters in a 20 µm thick AAO template, and 
liberated GOx nanocapsules of identical samples after complete AAO template removal in 0.01 
M HCl and 0.005 M HCl respectively.  
 
Figure 7:  UV spectrometry absorbance data collected after 5 minutes for 32 nm diameter GOx 
nanocapsules before and after liberation in hydrochloric acid solutions with different 
concentrations. 
 
The results confirm that the GOx maintained activity after template dissolution and that the 
activity of the liberated GOx nanotubes was actually greater than the template bound nanotubes.  
This result can be attributed to the diffusion limited transport of both reactants and products in 
 31 
confined high-aspect-ratio nanochannels for the template bound nanotubes.  While in the case of 
liberated protein nanocapsules in solutions, there are no significant barriers to mass transport.  
Figure 7 also shows that the activity of nanotubes liberated in 0.005 M HCl solution was 
comparatively higher than the activity of nanotubes when liberated in 0.01 M HCl solution. The 
results indicate that the concentration of the acid solution used had a considerable affect on the 
activity of the liberated nanotubes.  This observation led us to further study the impact of 
different acidic solutions on the GOx enzymatic activity.  For example, we examined the activity 
of bulk glucose oxidase in the presence of phosphoric acid solutions with concentrations ranging 
from 0.001 M to 0.1 M.  The experiments revealed that the biochemical activity of bulk GOx 
could only be maintained using phosphoric acid solutions with concentrations equal to or less 
than 0.01 M.  At such a low concentration the AAO templates could not be fully dissolved within 
a reasonable length of time. However, by using a low concentration (<0.02 M) solution of 
hydrochloric (HCl) acid we were able to both retain the protein biochemical activity and dissolve 
the AAO templates. 
We also compared the relative activity of template bound nanotubes with various 
diameters and wall thicknesses.  To compare the effect of nanotube diameter, templates with 
nanopores of 200 nm, 70 nm, and 32 nm diameter were coated with one layer of GOx.  Figure 8, 
showed that as expected the protein nanotubes in a 200 nm diameter template yielded the highest 
activity.   
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Figure 8: UV spectrometry absorbance data collected after 5 minutes for single layer template 
bound protein nanotubes within 32 nm, 70 nm, and 200 nm diameter nanopores. 
 
The 70 nm diameter nanotubes, however, had the lowest activity, which was slightly less than 
the 32 nm diameter.  These results can be attributed to the combined effect of diffusion limited 
transfer of reactants and products within the smaller nanochannels and the amount of adhered 
protein per unit area.  In a previous study, it was noticed that when the GOx nanotube wall 
thickness increased from 1 layer up to 6 layers, which led to the decrease in the size of 
nanochannel openings, the measured enzymatic activity of the GOx nanotubes first increased 
then decreased [32].  The turning point was the 3 layer GOx coating. Combined with our results, 
it is strongly indicated that depending on the aspect ratio of the nanochannels, the diffusion 
limited transport kicks in at a certain critical point.  Our results on the 70 nm and 32 nm cases 
suggest that not only diffusion limited transport affects the measured activity, but differences in 
the relative amount of protein per unit area also contributes.  The total surface area available per 
unit sample size for protein immobilization was analyzed as a function of pore diameter and 
spacing.  It was found that the nanopore array with 32 nm diameter provided the greatest amount 
of inner pore surface area per unit template size, which very likely leads to the result of larger 
amount of protein molecules immobilized in the nanopores of 32 nm diameter than that of the 70 
nm diameter.  Therefore the more protein per unit sample size the higher the measured enzymatic 
activity.  This might outweigh the effect of diffusion limited transport in nanochannels and 
account for the fact that the activity of the 32 nm diameter nanotubes was slightly greater than 
the 70 nm diameter nanotubes.   
Additionally, activities of template bound GOx nanotubes with various protein wall 
thicknesses were compared.  Figure 9 shows the measured activities of 1-, 2-, and 4- layers of 
GOx coated on the inner walls of an AAO template with nanopores of 70 nm diameter.   
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Figure 9:  UV spectrometry absorbance data collected after 5 minutes for 70 nm diameter 
template bound GOx nanotubes with varying wall thickness. 
 
It is clearly shown that the activity decreases consistently with increasing wall thickness.  These 
results further suggest that when the accessible amount of protein per unit sample size is the 
same, diffusion limitations plays a major role in determining the protein activity. 
CONCLUSIONS 
A template based nanofabrication method was developed to fabricate nanocapsules from 
proteins.  This method can be easily adapted to a variety of different proteins since the cross 
linking agent GA immobilizes all different types of proteins.  The ability to form nanocapsules of 
varied lengths and wall thicknesses can be beneficial for potential drug delivery and gene therapy 
applications.  Our future work will explore proteins suitable for drug encapsulation and cellular 
uptake, and will focus on optimizing the cleaving process to gain precise control over the length 
of the protein nanocapules. 
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ABSTRACT 
One-dimensional protein nanostructures offer many advantages for biomedical 
applications.  Rather than fabricate primary nanostructures with inorganic materials then 
functionalize with proteins, it is desirable to develop a fabrication method to make 
nanostructures that are entirely protein.  Fabrication of protein and polymer nanostructures is 
possible by layer-by-layer assembly within nanoporous templates.  Typically these structures are 
composites of two or more materials.  Few studies have demonstrated the fabrication of single 
component protein nanostructures using this method.  In this paper, we report our effort towards 
the fabrication of single-component avidin nanotubes using a layer-by-layer electrostatic 
assembly method adapted from literature.  We investigated the use of two different template pre-
treatment methods to strengthen the attraction between the initial protein layer and our template.  
During our investigation, we revealed a significant flaw with the published works upon which 
our fabrication method was based which seriously compromised the legitimacy of the approach.  
As a result, we modified our initial method and we are able to demonstrate the fabrication of 
glucose oxidase/avidin nanostructures using an electrostatic layer-by-layer assembly in 
conjunction with one of the template pre-treatment methods we investigated.    
INTRODUCTION 
Protein nanostructures show great potential for many biomedical applications such as 
biosensors, enzymatic bioreactors, bioseparations, and drug delivery [1-8].  Functionalizing 
inorganic nanotubular structures with proteins, enzymes, and antibodies has recently attracted a 
lot of interest for biomedical applications [1-6].  For example, antibodies have been 
functionalized on the inside and outside surfaces of silica nanotubes to separate racemic mixtures 
of drug formulations [6,9], silane chemistry was used to functionalize the inside and outside 
surfaces of silica nanotubes to give both hydrophilic and hydrophobic surfaces for the removal of 
lipids from aqueous solutions [3,5] and single walled carbon nanotubes have been functionalized 
with metelloproteins and enzymes for biosensing applications [4,5].  Using proteins and enzymes 
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as the main component of the nanostructure alleviates the need for additional functionalization 
and raises fewer biocompatibility concerns than inorganic materials such as carbon nanotubes. 
Recent discoveries suggest that one-dimensional nanostrucures may have great potential 
for success as drug and gene delivery vehicles.  Studies have shown that wormlike, filamentous 
nanoparticles are able to better avoid the body’s natural immune response than spherical 
particles, allowing them longer circulation [6-8].  It is hypothesized that macrophages, the cells 
that are responsible for engulfing foreign particles in a process known as phagocytosis,  have 
difficultly stretching and adjusting their shape to engulf filamentous particles.  Geng et al have 
demonstrated that paclitaxel loaded filomicelles can circulate up to ten times longer, and provide 
the same therapeutic effect as sphereical micelles with an eightfold smaller paclitaxel dosage per 
injection [7,8].  These results show great potential and demonstrate the need to further 
investigate the function of size and aspect ratio for delivery applications.  Therefore, it is 
necessary to develop low cost, simple, and versatile nanofabrication techniques to produce 
cylindrical protein and polymer nanostructures with controllable dimensions such as length, 
diameter, and aspect ratio. 
Recently template-assisted layer-by-layer assembly approaches have become popular 
methods to fabricate polymer and protein nanotubular structures [10-16].  These methods utilize          
nanoporous membranes such as anodized aluminum oxide (AAO) or polycarbonate as templates 
in which the nanopore walls are coated with polymer and protein layers.  To avoid the use of 
glutaralydehyde (GA) as a means to bind multiple protein layers [2,15,17,18], layer-by-layer 
electrostatic deposition has been adapted to electrostatically immobilize subsequent layers within 
the nanopores.  The electrostatic layer-by-layer method has been traditionally used to fabricate 
multilayer films on planar surfaces and colloid particles due to its low cost, simplicity, and 
versatility [10,11].  To date, nanotubes that have been fabricated using this method are primarily 
composites of at least two different oppositely charged proteins or polymers [11-16, 19].  For 
example, poly(ethylenimine) (PEI), a cationic polymer, was used to pre-treat alumina templates, 
followed by the alternate adsorption of poly-(sodium styrenesulfonate) (PSS) and cytocrome c to 
investigate the use of cytochrome c nanotubes for biosensor and enzymatic bioreactor 
applications [15].  Similarly, PEI was used to pre-treat polycarbonate templates, followed by the 
alternate adsorption of poly(acrylic acid) (PAA) or PSS and poly(allylamine hydrochloride) 
(PAH) [16], and chitosan (CHI) and alginate (ALG) were alternately adsorbed onto alumina 
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templates to form ALG/CHI nanotubes [12].  Only a few of these studies have demonstrated the 
ability to fabricate single component nanotubes with human serum albumin (HSA) using the 
layer-by-layer method [13,14].      
In this paper we report our efforts towards the fabrication of single component avidin 
nanotubes based on the previously published layer-by-layer electrostatic assembly of HSA 
nanotubes [13,14].  We investigate the use of template pre-treatment methods, i.e. covalent 
bonding via GA and the use of a cationic polymer PEI, to strengthen the attraction between the 
initial avidin layer and the AAO template to achieve mechanically stable structures.  In addition, 
we demonstrate the fabrication of glucose oxidase/avidin nanotubes using template pre-treatment 
with GA in conjunction with electrostatic layer-by-layer assembly. 
Avidin was chosen to be the main component of our nanostructures due to its many 
attractive qualities.  Avidin is a highly stable glycoprotein found in egg white and is well known 
for its strong binding affinity for biotin.  Avidin consists of four identical subunits each of which 
have one biotin binding site [20,21].  Avidin is a positively charged protein at neutral pH and has 
an isoelectric point of approximately 10 [21].  It is speculated that these properties may be 
responsible for the ability of avidin to localize rapidly within intraperitoneal tumors [21,22].  
This unique ability combined with the biotin binding properties of avidin make it a highly 
desirable protein for the delivery of drugs or therapeutic genes to tumors.  
EXPERIMENTAL 
Materials 
AAO membranes (13 mm) were purchased from SPI supplies with an average pore diameter of 
approximately 200 nm and thickness of 60 um.  The PEI, glucose oxidase, avidin, 3-amino 
propylphosphonic acid (APA), and GA were purchased from Sigma.  All chemicals were used as 
received without further purification. 
Template Pre-treatment 
AAO templates were pre-treated using two different methods aimed to enhance the 
binding of the initial protein layer to the template by either covalent crosslinking or electrostatic 
adsorption.   
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To covalently crosslink the initial protein layer, the AAO templates were sputter coated 
with Au/Pd and immersed in a 5 mM solution of APA at pH 5.8 for 24 hours.  After washing 
with 0.01 M phosphate buffer solution (PBS), the templates were immersed in a solution of 2.5% 
GA in PBS for 12 hours.  This process functionalizes the inner nanopore walls with aldehyde 
groups that can easily bind the free amino groups of proteins.    
To electrostatically absorb the initial protein layer, the AAO templates were immersed in 
a 10 mg/mL solution of PEI (pH adjusted to 3 using concentrated HCl) for 1 hour.  This process 
coats the nanopore walls with a thin film of cationic polymer giving them a net positive charge.   
Layer-by-Layer Assembly 
Avidin nanotubes were fabricated using untreated, PEI pre-treated, and APA and GA pre-
treated AAO templates.  For both of the pre-treated templates, PBS was first filtered through the 
template, followed by an avidin solution in a phosphate buffer with basic pH.  At a basic pH that 
is above avidin’s isoelectric point the avidin molecules carry a net negative charge. This net 
negative charge will enable electrostatic binding with the cationic PEI pre-treated template.  The 
net charge of the first avidin solution filtered through the APA and GA pre-treated templates is 
not important because the binding will be covalent and will utilize free amine groups.  Following 
the alkaline solution, an avidin solution in phosphate buffer with acidic pH was filtered through 
the template.  At an acidic pH that is below avidin’s isoelectric point the avidin molecules carry a 
net positive charge.   For the untreated AAO templates, the acidic avidin solution was filtered 
through before the basic avidin solution, because the AAO templates are negatively charged.  
The filtration of PBS and the two oppositely charged avidin solutions was repeated to build up 
the nanotube wall thickness.  During this study we evaluated different experimental parameters 
including the pH of the acidic and basic buffer solutions, the filtration method (vacuum or 
syringe filtration), avidin concentration, volume of solution, and number of fabrication steps.  
The experimental matrix we evaluated is given in table 1.   
 
 
 
 
 42 
Table 1: Experimental matrix showing the fabrication conditions for avidin nanotubes   
Method 
of Filling 
Template   
Pre-treatment 
Acidic 
pH 
Basic 
pH 
Acidic 
Charge 
Basic 
Charge 
Conc. 
Vol. per 
area* 
Filtration 
Steps 
vacuum 
filtration 
untreated 5 12 + 10.3 mV - 12.3 mV 1 mg/mL 
0.002 
mL/mm
2
 
5 
vacuum 
filtration 
untreated 5 12 + 10.3 mV - 12.3 mV 1 mg/mL 
0.004 
mL/mm
2
 
5 
vacuum 
filtration 
untreated 3 12 + 19.8 mV - 7.1 mV 4 mg/mL 
0.015 
mL/mm
2
 
3 
syringe 
filtration 
untreated 3 12 + 19.8 mV - 7.1 mV 4 mg/mL 
0.008 
mL/mm
2
 
4 
vacuum 
filtration 
PEI 8 12 + 7 mV - 12.3 mV 1 mg/mL 
0.002 
mL/mm
2
 
10 
vacuum 
filtration 
PEI 3 12 + 23.1 mV - 12.3 mV 1 mg/mL 
0.002 
mL/mm
2
 
10 
soaking PEI 3 12 + 23.1 mV - 12.3 mV 1 mg/mL 
0.008 
mL/mm
2
 
for 1hr 
- 
vacuum 
filtration 
APA + GA 3 12 + 23.1 mV - 12.3 mV 1 mg/mL 
0.002 
mL/mm
2
 
5 
* Volume of solution filtered per surface area of the AAO template 
 
Glucose oxidase/avidin nanotubes were fabricated using untreated and APA and GA pre-
treated AAO templates.  For both templates, 200 µL of each PBS, glucose oxidase (1 mg/mL in 
PBS pH 7), and avidin (1 mg/mL in PBS pH 7) were sequentially vacuum filtered through the 
templates.  The filtration of PBS and the two proteins was repeated 15 times to build up the 
nanotube wall thickness. 
The AAO templates were dissolved using NaOH or H3PO4 solutions of different 
concentrations to determine the most suitable solvent to maintain protein structure and 
bioactivity.  After template dissolution the nanotubes were collected by vacuum filtration on a 
polycarbonate filter with 50 nm diameter pores.  The nanotubes were washed several times with 
PBS and sonicated to disperse them for transmission electron microscopy (TEM) sample 
preparation.   
Characterization   
Nanotube morphology was characterized using scanning electron microscopy (SEM) and 
TEM.  The nanotube samples were sonicated to disperse them for TEM sample preparation.  
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UV-vis spectrometry was used to evaluate avidin stability in the acidic and basic buffer 
solutions.  The UV-vis spectra were obtained using a Genesys 10UV scanning 
spectrophotometer from Thermo Electron.  Zeta potential was used to measure avidin charge in 
the acidic and basic buffer solutions.  Zeta potential was measured using a ZetaSizerNano from 
Malvern.  
RESULTS AND DISCUSSION 
Avidin nanotubes 
In order to determine the optimum solution conditions for the fabrication of our single 
component avidin nanotubes, we used UV-vis absorption to verify the stability and secondary 
structure of avidin in highly acidic and basic solutions [8] and used zeta potential to verify that 
avidin would be oppositely charged in solutions above and below the isoelectric point and to 
determine the optimum solution concentration for maximum charge density.  The UV-vis spectra 
obtained for for avidin solutions with pH values of approximately 3, 5, 9 and 12 is shown in 
Figure 1.   
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Figure 1. UV spectra of 1 mg/mL avidin solutions at pH 3, 5, 9 and 12. 
 
When avidin is denatured in acidic solutions, the tryptophan residues present in the molecule 
become exposed and cause an increase in the absorbance at 233 nm [25].  Figure 1 shows that 
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avidin at pH 3 has the highest absorbance at 233 nm and may be slightly denatured.  Despite this 
observation, it was demonstrated previously by Green [25] that avidin does not completely and 
irreversibly denature until pH values less than 2.  When avidin is denatured in basic solution, the 
tyrosine residues present in the molecules are ionized and cause an increase in the absorbance at 
246 nm [25].  Again, this increase is observed in our UV-vis spectrum, showing that some of the 
tyrosine was ionized at pH 12 and this result was also demonstrated by Green in alkaline 
solutions [25].  Through reverse titrations, Green demonstrated that after exposure to a high pH 
of approximate 13, avidin showed only 5-10% inactivation depending on the duration of the high 
pH exposure [25].  Green’s work confirms that use of buffer solutions up to pH 13 could 
potentially be used for our proposed electrostatic layer-by-layer assembly process.  Both Green’s 
work with avidin under extreme pH conditions [25] and our UV-vis spectrum, shown in figure 1, 
demonstrate that pH values within the range of 3 to 12 could be used without significant concern 
for avidin stability. 
The zeta potential of avidin was measured as a function of buffer solution pH and avidin 
concentration in order to determine the optimum solution properties for electrostatic binding.  
Figure 2 shows the zeta potential as a function of pH for 0.5 and 1 mg/mL avidin solutions.  
Below pH 5 and above pH 9 it can be seen that the zeta potential changes significantly with 
small changes in pH.   
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Figure 2:  Zeta potential of 0.5 mg/mL and 1 mg/mL avidin solutions as a function of buffer pH.  
The error bars as given by the standard deviation of 3 measurements.  
 
We chose to use solution pH values of 3, 5 and 8 below the isoelectric point and a solution pH of 
12 above the isoelectric point.  We chose to use only one basic pH value because of the limited 
range of pH values above the isoelectric point where avidin is stable.  We chose our acidic pH 
values for the following reasons: pH 8 is two pH values below the isoelectric point and was 
chosen to correspond to the basic pH of 12, which is two pH values above the isoelectric point, 
pH 5 has an approximately equal but opposite zeta potential value as the pH 12 solution, and pH 
3 was chosen because it is the lowest pH value possible to maintain stability and give the 
maximum positive charge.  The data presented in figure 2 also show that the zeta potential is 
influenced by the solution concentration.  The zeta potential for the lower solution concentration 
(0.5 mg/mL) showed a smaller positive charge for all pH values below the isoelectric point and a 
smaller negative charge for all pH values above the isoelectric point in comparison with the 
higher solution concentration (1 mg/mL).  This observation led us to measure the zeta potential 
at a higher solution concentration to see if the upward trend would continue. 
The zeta potential is shown in Figure 3 as a function of solution concentration for avidin 
in pH 12 and pH 3 phosphate buffer solutions. 
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Figure 3: Zeta potential as a function of solution concentration for pH 3 and pH 12 buffer 
solutions.  The error bars are given by the standard deviation of 3 measurements. 
 
We find that increasing the avidin concentration from 1 mg/mL to 4 mg/mL actually decreases 
the absolute positive and negative charge observed for our two extreme pH 3 and pH 12 
solutions respectively.  Therefore we chose to use an avidin concentration of 1 mg/mL for the 
majority of our fabrication efforts for the largest net charge of avidin, but also chose to 
experiment with a concentration of 4 mg/mL to investigate the effect of an increased number of 
protein molecules per unit volume. 
 The layer-by-layer electrostatic assembly of avidin nanotubes was first attempted using 
untreated AAO templates.  This method was adapted based on the results published by Lu et al. 
[13,14] who demonstrated the fabrication of HSA nanotubes by alternating the filtration of 
oppositely charged HSA solutions at pH values of 3.8 and 7.0 through AAO templates.  
Similarly, we alternately filtered oppositely charged avidin solutions through AAO templates 
according to the condition given in table 1.  After several fabrication attempts using a variety of 
different conditions, the SEM and TEM results we obtained revealed that we were not able to 
make avidin nanotubes.  An SEM image of a partially etched untreated AAO template after 5 
avidin filtration steps using pH 3 and pH 12 and etched with 10% H3PO4 is shown in figure 4a.  
The nanopores of the original AAO template are very obviously observed as well as some 
material on the surface which may be avidin.  Although the image shown in figure 4a 
corresponds to one particular set of experimental conditions, it is representative of the results 
obtained for all experimental trials using untreated templates detailed in table 1.  We did not find 
any nanostructures during our TEM characterization.  We hypothesize that our unsuccessful 
attempt may be the result of a weakly absorbed initial avidin layer.  It may be possible that the 
electrostatic attraction between the negatively charged untreated AAO template and positively 
charged avidin in solution is not strong enough to form a continuous, uniform initial layer.  
Without a strongly bound and continuous initial layer, the subsequent layers will also have weak 
interactions and will hinder the electrostatic assembly of multiple layers needed form our desired 
nanotube structures. 
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Figure 4: SEM images of AAO templates after partial etching with 10% H3PO4 for ~3hrs: a.) 
untreated AAO templates after 5 avidin filtration steps (scale bar = 1µm), b.) AAO templates 
pre-treated with APA and GA after 5 avidin filtration steps, c.) AAO templates pre-treated with 
PEI after 5 avidin filtration steps (scale bar = 1µm). 
 
To investigate whether our problem is partly do the continuity and uniformity of the 
adsorbed layers, we filtered two avidin solutions (1 mL, 4 mg/mL, pH 3 and 1 mL, 4 mg/mL, pH 
12) through the AAO template 4 times and measured the absorbance of the two solutions after 
each filtration step to see if the concentration of the avidin solutions decreased.  Figure 5 shows 
the absorbance at 295 nm for the two avidin solutions after each of the 4 filtration steps.  The 
same solution was reused after each filtration step.   
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Figure 5: Graph showing the absorbance of avidin solutions (1 mL, 4 mg/mL, pH 3 and 1 mL, 4 
mg/mL, pH 12) after a total of 4 consecutive filtration steps. 
 
The absorbance for the pH 3 solution decreased from its initial value at 1.722 which corresponds 
to a concentration of approximately 4 mg/mL down to 1.094 after the 4th filtration step, which 
corresponds to a concentration of approximately 1.6 mg/mL.  The absorbance for the pH 12 
solution initially increased from 1.781 to 1.809 after the first filtration step, which suggests that 
some of the avidin deposited during the 1st pH 3 filtration step was unattached and washed out 
with the pH 12 solution.  After the second filtration step, the absorbance of the pH 12 solution 
decreased, and continued to decrease for the remaining filtration steps down to 1.481 after the 4th 
filtration step and corresponds to a concentration of approximately 2.9 mg/mL.  Overall, these 
results suggest that the initial avidin layer deposited at pH 3 is only weakly attached to the AAO 
template as we hypothesized.  However, our results also suggest that avidin is deposited within 
the AAO template during the subsequent filtration steps.  Our inability to obtain SEM and TEM 
evidence to demonstrate that the deposited avidin layers form nanostructures within the AAO 
templates further supports our hypothesis that the deposition and filling of the protein is 
discontinuous and not uniform.   
This led us to explore template pre-treatment methods to strengthen the initial attraction 
between the AAO template and avidin.  We employed two different template pre-treatment 
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methods; covalent crosslinkers or a cationic polymer.  The first pre-treatment method we 
investigated was to use the covalent crosslinkers APA and GA to initially functionalize the inner 
walls of the AAO template with aldehyde groups for covalent attachment of the initial protein 
layer.  This pre-treatment method was chosen based on our previous experience using it to 
demonstrate glucose oxidase nanocapsules [18].  Again, after 5 avidin filtration steps through the 
APA and GA pre-treated templates we did not find any nanostructures during our TEM 
characterization.  However, our SEM investigation revealed some collapsed and apparently 
mechanically weak nanostructures protruding from our partially etched AAO templates, which 
can be seen in figure 4b. 
Our second pre-treatment method, using PEI a cationic polymer, to give the AAO 
template an initially positive charge, was chosen based upon its use in literature as the first layer 
for the layer-by-layer electrostatic assembly of alginate/chitosan [12] and cytochrome c/PSS [15] 
nanotubes within nanopores.  Both studies showed convincing SEM and TEM images of their 
protein nanostructures.  When we used PEI to pre-treat our templates, however, we observed 
SEM and TEM results that were similar to our APA and GA pre-treated templates; partially 
collapsed and mechanically weak nanostructures via SEM, shown in figure 4c, and no 
nanostructures observed via TEM.  The difference between our attempt to fabricate protein 
nanotubes within PEI pre-treated templates and those presented in literature [12,15] was the use 
of a single protein at different pH values rather than two different oppositely charged proteins or 
polyelectrolytes.   
The results obtained for both pre-treatment methods led us to the hypothesis that our 
fabrication approach has not been successful because alternating solutions of different pH may 
cause some charge reversal of the already adsorbed proteins resulting in the deposition of protein 
layers that are not uniform or complete.  The non-uniformity and discontinuous nature of the 
protein layers that we deposited may explain why we observed some collapsed and mechanically 
weak structures via SEM, but then nothing via TEM after the AAO template is completely 
removed.  After complete removal of the AAO template, the avidin layers no longer have any 
mechanical support and may fall apart.  Additionally the sonication that is necessary to disperse 
the nanotubes for TEM may contribute further to the break down of any weak nanostructures that 
may have been formed.              
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After several unsuccessful attempts to demonstrate conclusive SEM and TEM evidence 
of avidin nanotubes using untreated AAO templates and two different pre-treatment methods in 
conjunction with our electrostatic layer-by-layer assembly method, we returned to our literature 
review to re-examine the papers upon which this study was based.  Since we adapted our 
experimental method based on previous established and published methods, we expected to 
observe mechanically stable, thick walled nanostructures like those presented for single 
component HSA nanotubes [13,14].  The SEM images presented in figure 4 clearly show that 
this was not the case.  Paying closer attention to the details presented in previously published 
works, we discovered that we overlooked an important step in the SEM sample preparation 
described by Lu et al. [14].  Before dissolving their AAO templates, they fixed them on silicon 
wafers using epoxy resin.  Epoxy is a two component polymer system that is initially liquid and 
hardens after the two components are mixed.  Our previous experience with polymer solutions 
and template wetting [26,27] led us to the hypothesis that Lu et al may have filled their AAO 
templates with epoxy in addition to protein.  To test this hypothesis, we fixed an empty AAO 
template to a silicon wafer using commercially available superglue (Elmer’s Instant Krazy Glue).  
After partially etching the AAO template, we observed superglue nanotubes, shown in figure 6, 
which are remarkably similar to those presented in Lu et al’s publications [13,14].  Although 
superglue is a low viscosity cyanoacrylate and epoxy resins, in comparison, are much more 
viscous we still expect the epoxy to wet the AAO template in a similar fashion.  It should also be 
noted that TEM images of the alleged HSA nanotubes are not shown in either publication, 
raising serious doubts regarding the fabrication of mechanically stable, purely protein nanotubes.  
Given the similarity of the SEM images and lack of TEM evidence it would be difficult to claim 
that the nanotubes presented by Lu et al. are pure protein nanotubes without epoxy.  The 
combination of this new evidence and our unsuccessful fabrication attempts, indicate that we 
cannot draw any real conclusions regarding the feasibility of this fabrication approach for single 
component protein nanotubes.   
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Figure 6:  SEM images of superglue nanotubes fabricated by fixing initially empty AAO 
templates to silicon wafers with superglue (template wetting). 
 
Glucose oxidase/avidin nanotubes 
To test our hypothesis regarding the use of two different oppositely charged proteins for 
electrostatic assembly, we proceeded to fabricate glucose oxidase/avidin nanotubes using layer-
by-layer electrostatic assembly in conjunction with APA and GA pre-treated AAO templates.  
Since glucose oxidase has an acidic isoelectric point (pH 4.2) and avidin has a basic isoelectric 
point (pH 10), when they are in a neutral buffer solution they possess an opposite net charge 
which enables electrostatic binding.  We again chose to use APA and GA to pre-treat our AAO 
templates based on our previous work [18].  TEM images of the glucose oxidase/avidin 
nanotubes are shown in figure 7. 
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Figure 7:  TEM images of glucose oxidase/avidin nanotubes fabricated by electrostatic layer-by-
layer assembly using an APA and GA pre-treated AAO template. 
 
This demonstrates that layers of oppositely charged proteins, glucose oxidase and avidin, can be 
built up electrostatically within the pre-treated nanopores.  This result supports the claims made 
in previously published studies regarding the feasibility of layer-by-layer electrostatic assembly 
within nanopores [11-16, 19].    
Careful examination of the thickness of the protein nanotube walls using the image 
processing software imageJ [23] reveals that the average wall thickness (measured in 15 different 
places) is 55.3±9.3 nm.  Based on the size of a glucose oxidase molecule (approximately 5.5 x 7 
nm) [18] and an avidin molecule (approximately 5.5 x 6 x 4 nm) [24] an average nanotube wall 
thickness of 55.3 nm could only accommodate approximately 5 layers of each glucose oxidase 
and avidin.  Therefore, we hypothesize that each of the 15 vacuum filtration steps employed to 
fabricate these nanostructures still did not deposit full protein layers within the AAO template 
despite the use of different oppositely charged proteins.  This might be due to the small volume 
of the solution we used.  The TEM images of our glucose oxidase/avidin nanotubes, shown in 
figure 7, demonstrate that even with small filtration volumes we were still able to build up 
relatively thick nanotube walls electrostatically by using two proteins that were oppositely 
charged at pH 7 to make mechanically stable protein nanostructures.       
CONCLUSIONS 
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In conclusion, we have reported several hypotheses regarding our unsuccessful attempts 
to fabricate single component avidin nanotubes using a layer-by-layer electrostatic assembly 
method adapted from literature.  Additionally, we have shown there to be a critical problem with 
the preparation of the SEM samples of the single component HSA nanotubes upon which our 
method was adapted.  This issue prevents meaningful conclusions from being drawn regarding 
the feasibility of electrostatic layer-by-layer assembly to fabricate single component protein 
nanotubes.  Despite our unsuccessful attempts with single component avidin nanostructures, we 
were able to successfully demonstrate a method to fabricate glucose oxidase/avidin 
nanostructures using layer-by-layer electrostatic assembly in conjunction with APA and GA 
template pre-treatment.  
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ABSTRACT 
Segmented polystyrene (PS) and poly(methyl methacrylate) (PMMA) nanofibers were 
fabricated by wetting nanoporous alumina templates with multilayered polymer thin films.  The 
order and thickness of the polymers within the thin films affected the resulting nanofiber 
morphology, PS and PMMA segment properties, and created unique core-shell structure in the 
PMMA segments.  The core-shell structure suggests a complex wetting phenomenon.  
Fabrication of polymer nanostructures by wetting of layered thin films opens the arena of 
multifunctional, one-dimensional, polymer nanostructures with segments having individual and 
specific functionalities.   
INTRODUCTION 
 One-dimensional nanostructures offer a wide range of opportunities for a number of 
scientific fields.  The resemblance of nanofibers and nanotubes to pipes, cavities, capsules and 
wires and the ability to fabricate them from metals, semiconductors, ceramics, and polymers lend 
them to an endless number of potential applications [1].  The ability to fabricate polymer 
nanofibers and nanotubes is of particular interest because of the vast array of natural and 
synthetic polymers available.  The utility of polymer nanostructures could be further exemplified 
with a technique to fabricate heterogeneous nanostructures with discrete and/or alternating 
segments that provide individual and specific functionalities.  This concept has not yet been fully 
explored for one-dimensional polymer nanostructures.  In this communication  a variation of the 
well known template wetting approach is introduced to fabricate alternating, segmented 
nanofibers of polystyrene (PS) and poly-methylmethacrylate (PMMA) and opens the idea of 
polymer nanofibers with multiple, discrete, segmented functionalities to the scientific 
community. 
Template wetting is a well established template-assisted nanofabrication approach for 
producing one-dimensional nanostructures [1,2].  It is easy, cost effective, and accommodates 
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almost all types of polymeric materials.  High energy porous materials such as anodized 
aluminum oxide (AAO) or silicon are generally utilized for the wetting of low energy polymer 
melts [1,2].  Two wetting regimes can be achieved, complete wetting or partial wetting, to 
produce either nanotubes or nanofibers respectively.  Complete wetting occurs when the 
interfacial driving force is high, causing a thin film of polymer to spontaneously form over the 
entire nanopore surface area in a very short span of time.  Partial wetting, on the other hand, 
occurs when the interfacial driving force is low.  With a low driving force, the polymer melt 
slowly travels up the nanopore channel is a plug via capillary force to form nanofibers.  The 
formation of nanotubes versus nanofibers can be controlled by varying the melt temperature, 
which affects the polymer interfacial tension [3].  At temperatures only slightly above the 
polymer glass transition temperature (Tg), the polymer interfacial tension is high and nanofiber 
morphology is favored [3], as illustrated in Figure 1 (a) and (b), which show both a transmission 
electron microscope (TEM) and scanning electron microscope (SEM) image of PS nanofibers 
obtained by wetting an AAO template with a thin film of PS at 150oC for 48 hours.   
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Figure 1: PS nanofibers fabricated by template wetting at 150oC for 48 hrs. a.) TEM image 
showing completely filled nanofiber structure with meniscus. b.) SEM image showing the 
dimpled tips of nanofibers in a partially dissolved AAO template resulting from the formation of 
a meniscus in the nanopore.  PS nanotubes fabricated by template wetting at 200oC for 10 
minutes. c.) TEM image showing the hollow center and wall of the nanotube. d.) SEM image 
showing the opened tips of nanotubes in a partially dissolved AAO template.  
 
At temperatures much greater than the polymer Tg, the polymer interfacial tension is low and 
nanotube morphology is favored [3], as illustrated in Figure 1 (c) and (d), which show a TEM 
and SEM image of PS nanotubes obtained by wetting an AAO template with a thin film of PS at 
210oC for 10 minutes.  These results indicate that there exists a certain wetting transition 
temperature for all polymers at which the wetting regime changes from partial to complete 
wetting [3].  In addition to melt temperature, the polymer interfacial tension is also a function of 
the polymer molecular weight and the interfacial driving force can be further affected by varying 
the pore diameter of the template [3]. 
 Within the past 15 years a great amount of progress has been made by researchers to 
better understand the wetting of porous materials and utilize this phenomenon to create a wide 
array of functional nanomaterials.  Steinhart et al. first demonstrated PS, poly-tetrafluoroethylene 
(PTFE), and PMMA nanotubes by template wetting and introduced the concept of adding 
functionality by preparing palladium/polymer composites through wetting with a solution of 
poly-L-actide (PLLA) and palladium(II) acetate [4].  Since the introduction of template wetting 
researchers have explored many different variations of this process to produce unique structures.  
One group fabricated PS nanofibers with partially exposed tips and hydrophilically 
functionalized them to create hydrophilic-tipped hydrophobic PS nanofibers [5], while others 
have experimented with co-polymer template wetting using PS-b-PMMA [6] and 
poly(vinylidene fluoride-trifluoroethylene) for energy transduction and information recording 
[7].  This process can even accommodate biodegradable polymers such as poly(ε-caprolactone) 
(PCL).  PCL nanofibers were fabricated for biomedical applications in which controlled release 
is desired [8].  More recently a bidirectional template wetting [9], also referred to as face-to-face 
wetting [10], was introduced where both surfaces of the porous template are simultaneously 
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wetted. This variation was used to create one dimensional nanosturctures with two different 
materials to produce either a discrete interface or polymer gradient between the two polymers.   
In this communication we introduce the idea of using multilayered polymer films to 
fabricate heterogeneous, segmented nanofibers via nanoporous template wetting.  PS and PMMA 
were chosen as a model system.  The thin film properties and interfacial energies associated with 
PS and PMMA have been extensively studied [11-13].  This knowledge helps to understand the 
unique morphology of our heterogeneous nanofibers.  By wetting AAO templates with 
multilayered, alternating PS and PMMA films of different layer thicknesses we were able to 
fabricate nanofibers with distinct segments of PS and PMMA and achieve very unique core-shell 
morphology in the PMMA segments.  
EXPERIMENTAL 
Spincoating polymer thin films 
PS (Mw =230,000) and PMMA (MW =120,000) were purchased from Sigma Aldrich.  
Polymer solutions were made by dissolving PS in toluene and PMMA in 2-Butanone.  Polymer 
solutions were spin coated using a Laurell Technologies model WS-65OS-6NPP/LITE spin 
coater with speeds from 500 – 8000 RPM, total spin times of 60s and acceleration of 10,000 
RPM.  Films were coated onto 18 mm2 glass coverslides. The thickness of the thin films was 
measured via UV-vis spectroscopy [14] using a Genesys 10UV scanning spectrometer. 
Template wetting 
Nanoporous AAO templates were purchased from SPI supplies.  The AAO templates 
were 60 µm thick and had an average pore size of 200 nm.  The AAO templates were placed on 
top of polymer thin films and the whole stack was heated to 150oC by hotplate for 48 hrs.  This 
temperature is 50oC above the Tg of both PS and PMMA, which have Tgs of approximately 
100oC.  After annealing and cooling to room temperature the polymer thin film was removed 
from the glass coverslip by soaking in DI water.  Next the alumina was dissolved in 1M NaOH, 
leaving only the polymer nanomaterials.  The nanofibers were collected by centrifuge, washed 
with DI water, and dispersed in ethanol by sonication.      
Characterization with TEM 
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Nanofiber morphology was analyzed using transmission electron microscopy (TEM).  
Prior to imaging, the nanofiber coated TEM grids were stained using RuO4, a well known gas 
phase stain which exclusively darkens PS [6, 15].  Briefly, RuCl3
.3H2O (0.2 g) was added to a 
solution of NaOCl (10 mL) to form RuO4.  A small amount of this mixture was placed inside one 
chamber of a dual chamber glass container.  The nanofiber TEM grid was place in the other 
chamber and exposed to the volatile RuO4 for approximately 1 minute. 
RESULTS AND DISCUSSION 
A multilayered polymer thin film with 1 µm PMMA, 4 µm PS, 1 µm PMMA, 4 µm PS, 
and 1 µm PMMA layers was used to wet an AAO template with nanopores of 200 nm diameter.  
The polymer nanofibers were released from the AAO template by dissolution of the AAO in 1 M 
NaOH solution and collected by centrifugation.  The PS segments of the nanofibers were 
darkened by staining with RuO4.  Characterization via TEM revealed distinct, dark PS segments 
ranging in length from 200 nm to 1 µm, shown in Figure 3a.   
 
Figure 3: TEM images of segmented PS and PMMA nanofibers. a.) Shows the short and varied 
length of the PS segments.  b.) Shows the length of the PMMA segments to be up to 5 µm.  
Darkened polymer segments are PS. 
 
The PS segments appear to be slightly larger in diameter than the PMMA segments due to a 
combination of the volume expansion of PS during staining and the electron irradiation-induced 
thinning of PMMA during imaging [6, 11].  The PMMA segments were typically longer than the 
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PS segments with PMMA segment lengths up to 5 µm, shown in Figure 3b.  This result was 
unexpected since the PS layers were 4 times thicker than PMMA layers.  Conservation of 
material demands that the PS must be accounted for somewhere in or along the nanofiber.  A 
closer look at the junction of the PS and PMMA segments reveals a unique core-shell 
morphology, shown in Figure 4.   
 
Figure 4:  TEM images of segmented PS and PMMA nanofibers showing the core-shell 
morphology of the PMMA segments.  Darkened polymer segments are PS. 
 
It is shown that the PMMA segments have a PS core.  This is understood based upon the 
behavior of PS and PMMA co-polymers and blends.  PMMA is more polar than PS and has been 
shown to preferentially wet the hydrophilic metal oxides surfaces before PS [11, 12].  This 
results in the formation of the PMMA shell and PS core.  The formation of core-shell 
morphology rather than a homogeneous segmented structure is due to a combination of the 
difference in PMMA and PS film thickness and the competitive interfacial driving forces present 
at the AAO template/polymer interface. 
CONCLUSIONS 
Heterogeneous, segmented PS and PMMA nanofibers with novel core-shell morphology 
have been fabricated via template wetting by multilayered, alternating PS and PMMA thin films.  
These unique structures offer great future opportunities including multifunctional nanofibers that 
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could theoretically be composed of any number of polymers with the desired functionalities and 
single polymer nanofibers with segments of different diameter by selectively dissolving the 
polymer shell in the core-shell segments.  Our future work will explore the formation and 
controllability of core-shell segments and will experiment with the formation of segmented 
polymer nanofibers with both tube and fiber morphology by template wetting of multilayered, 
alternating polymer films for potential drug delivery and biosensor applications.   
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Abstract 
One-dimensional core-shell polymer nanowires offer many advantages and great potential for 
many different applications.  In this paper we introduce a highly versatile two-step template 
wetting process to fabricate two-component core-shell polymer nanowires with controllable shell 
thickness.  PLLA and PMMA were chosen as model polymers to demonstrate the feasibility of 
this process.  Solution wetting with different concentrations of polymer solutions was used to 
fabricate the shell layer and melt wetting was used to fill the shell with the core polymer.  The 
shell thickness was analyzed as a function of the polymer solution concentration and viscosity 
and the core-shell morphology was observed with TEM.  This paper demonstrates the feasibility 
of fabricating polymer core-shell nanostructures using our two-step template wetting process and 
opens the arena for optimization and future experiments with polymers that are desirable for 
specific applications. 
 
Introduction 
One-dimensional (1D) nanostructures such as nanotubes and nanowires are receiving a 
great amount of attention for a variety of different applications including fluidics[1], 
purification[1], separation[1], gas storage[1], sensors[1-4], optoelectronic devices[2], 
catalysis[1,5], drug delivery[1,3,4,6],  and tissue engineering[3,5-7].  Recently, the realization of 
core-shell nanowires [1-12], has further expanded the potential of 1D nanostructures because of 
the ability to incorporate separate functionalities within the core and the shell material to achieve 
novel properties [3].   The realization of nanocables that have conductive metallic cores, such as 
silver, and insulating shells, such as silica, has shown great potential for nanoelectronic devices 
[2].   Other examples include polymer core-shell nanofibers with cores loaded with metal 
nanoparticles for catalysis[4], core-shell polymer nanofibers with the incorporation of enzymes 
into the core for controlled catalytic processes[7],  and the fabrication of water-soluble 
polyaniline (PANI) nanofibers wrapped in a schizophyllan coating for biological sensor 
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applications[3,9].  In addition, core-shell polythiophene/fullerene nanofibers have been 
fabricated to demonstrate that different charge transport behavior can be achieved for the core 
and shell materials and charge transport has been explored for polymer solar cell applications 
[10]; gold-PANI core-shell nano fibers have been fabricated for incorporation into solar-cell and 
OLED devices [11], and Si-CdSSe core-shell nanowires have been fabricated with continuously 
tunable band gap for light emission in the visible region [12].   
To date, core-shell polymer nanowires have been fabricated using a co-electrospinning 
method [1,3-6].  In addition to co-electrospinning, traditional electrospinning has been employed 
to fabricate the nanofiber core material in conjunction with coating processes such as chemical or 
physical vapor deposition, spin coating, or spraying to coat the core nanofiber with a layered 
shell [4].   
In this paper we describe the use of a template-assisted sequential solution wetting and 
melt wetting process to demonstrate the fabrication of heterogeneous core-shell polymer 
nanowires with adjustable shell thicknesses.  Template wetting is a simple, low cost, and 
versatile nanofabrication method, which relies on capillary forces to draw polymer solutions or 
polymer melts into the nanochannels of nanoporous materials to form either nanotubes or 
nanowires [13-18].  The template wetting process has been exploited to fabricate a wide variety 
of heterogeneous nanostructures including segmented nanowires [19,20], copolymer nanowires 
and nanotubes [21,22], and nanotubes with longitudinal composition gradients [23].  In our 
exploration, anodized aluminum oxide (AAO) templates with hexagonally ordered nanopore 
arrays were used as the basic template to demonstrate the fabrication of poly(L-lactic acid) 
(PLLA)-poly(methyl methacrylate) (PMMA) core-shell nanowires using our novel two-step 
wetting process.  PMMA was chosen as a model polymer for the nanowire shell because of its 
low cost and availability and PLLA was chosen in part for its low glass transition temperature in 
comparison with PMMA and based on our previous experiences with fabricating homogenous 
PLLA nanowires by melt wetting [24].  The importance of choosing a polymer for the core with 
a lower Tg than the shell polymer is discussed later.  The sequential solution wetting and melt 
wetting approach that is proposed in this paper to fabricate core-shell polymer nanowires is not 
limited to the use of AAO as a template material or to the particular polymers used in this study.  
Our fabrication process is easily adapted to almost any type of nanoporous or microporous 
material, like AAO and silica, or lithographically fabricated nanochannel arrays and any 
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combination of polymers.  In addition to versatility, our fabrication process also offers 
unprecedented control of the nanofiber morphology.  The shell thickness can be controlled by the 
polymer solution properties used for the initial wetting step, the diameter can be controlled by 
the diameter of the nanochannels of the template, and the maximum length of the nanowires can 
be controlled by the thickness of the template material.  For example, the diameter of the 
nanochannels of AAO templates is adjustable over a range of 20 nm – 300 nm and is controlled 
by the solution conditions used for electrochemical anodization and the thickness of AAO 
templates can range from tens of nanometers up to a few hundred microns and is controlled by 
the anodization time [25,26].  Figures 1a and 1b show SEM images of some of the pore sizes that 
can be achieved in our laboratory by varying the anodization conditions.  
For the purposes of this proof-of-concept study, commercially available AAO 
membranes were used for our template material.  Commercial AAO templates typically have less 
uniform pore diameters than the templates that can be fabricated in our laboratory.  For this 
reason, we have included a graph, shown in figure 1e, illustrating the pore size distribution of the 
commercially available templates used for this pioneering work and examples of the templates 
that can be fabricated in our laboratory.  The average pore size distribution was analyzed using 
the image processing software imageJ [27].     
 
 67 
 
Figure 1: SEM images of AAO templates (a) homemade with average pore diameter of 35 nm 
(b) homemade with average pore diameter of 52 nm (c) commercial with average pore diameter 
of 192 nm and (d) graph showing the distribution of pore diameters for the homemade versus 
commercial templates.  
 
Figure 1 shows that the pore diameter distribution is very large for the commercially available 
templates in comparison to the homemade templates. The templates in figures 1a, 1b, and 1c, 
were found to have average pore diameters of 35.3±4.4, 51.7±5.7, and 192±65 nm respectively.  
Although this wide distribution of pore diameters may affect the morphology of our 
nanostructures, we chose to use the commercial templates for convenience since this is a proof-
of-concept study.  Future process control and optimization experiments will utilize our 
homemade AAO templates. 
 
Experimental 
Materials 
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PLLA (Mw: 100,000 – 150,000 g/mol, Tg: 48.6
oC), PMMA (Mw: 996,000 g/mol, Tg: 105
oC) and 
methyl ethyl ketone (MEK) were purchased from Sigma Aldrich and used as received.  Anodisc 
13 commercial AAO templates with average pore diameter of ~190 nm were purchased from 
Whatman and used as received.   
 
Template Wetting 
AAO templates were wetted with 5%, 8%, 10%, or 15% PMMA solutions in MEK.  The wetted 
templates were left overnight under ambient conditions to allow the solvent to evaporate.  
Following solution wetting, a thin film of PLLA was placed on top of the template and was 
heated on a hot plate at 100oC for 2 hrs or 24 hrs.  After the wetting steps, both sides of the AAO 
template were sanded to remove excess polymer from the surfaces and the AAO template was 
completely etched in 2M NaOH.  The nanostructures were washed several times with DI water, 
and collected by centrifugation.   
 
Analysis of Nanofiber Morphology    
Nanofiber morphology was characterized with transmission electron microscopy (TEM).  Our 
TEM samples were prepared using carbon coated copper grids.  It was not necessary to stain the 
polymer nanowires before imaging because the PLLA core showed enough contrast without 
staining to differentiate the shell and core layers.  Aspects of the core-shell nanofiber 
morphology, such as shell thickness, diameter, and length, were analyzed using the image 
processing software imageJ [27].  Shell thickness, in particular, was measured 10 times from 
multiple TEM images for each PMMA solution concentration and the average and standard 
deviations were reported.   
 
Results and Discussion 
Polymer core-shell nanowires were fabricated by a sequential solution wetting and melt 
wetting process.  Solution wetting was used to deposit a thin film of polymer within the 
nanochannels of AAO templates to form the shell layer.  Solution wetting was chosen to 
fabricate the shell layer because melt wetting does not offer as many process variables to control 
the morphology and is generally limited to high molecular weight polymers [18].  The thickness 
of the thin film formed by solution wetting depends upon solution properties such as solvent 
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quality, polymer molecular weight, and solution concentration [18] as well as template attributes 
such as nanopore diameter, surface energy of the nanochannels, and the aspect ratio of the 
nanochannels.  For the purposes of this initial investigation, the shell thickness was varied by 
using different PMMA concentrations.  All other variables that affect shell thickness were held 
constant and will be investigated in the future.  Figure 2a shows a graph relating both the 
thickness of the PMMA shell and the natural log of the solution viscosity to the solution 
concentration.  The PMMA shell thickness is reported as the average and standard deviation of 
10 different measurements, as described in the experimental section.   
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Figure 2: (a) Graph showing the average wall thickness of the PMMA shell and the natural log of 
the solution viscosity as a function of the PMMA solution concentration in MEK. (b) Graph 
showing the average wall thickness of the PMMA shell as a function of the natural log of the 
PMMA solution viscosity. 
 
The calculated average wall thicknesses were found to have very large standard 
deviations.  Based on other studies which have shown there to be a linear relationship between 
wall thickness and pore diameter [18], we expect that the wide range of pore diameters of the 
commercial AAO templates used for this study leads to the correspondingly wide range of wall 
thicknesses that we observed.  Therefore, we attribute our large standard deviations to the wide 
pore diameter distribution that is observed for commercial AAO templates (figure 1).  Future 
studies that will aim to optimize this process to achieve more control over the wall thickness will 
utilize homemade AAO templates which have a much narrower pore diameter distribution than 
the commercial templates (figure 1).   
The increase in shell thickness that results from increasing the PMMA solution 
concentration appears to be a logarithmic relationship and therefore is likely a function of the 
solution viscosity.  Typically polymer solution viscosity increases exponentially with polymer 
concentration for a given molecular weight when the concentration is above some critical 
concentration.  The critical concentration, C*, is the concentration at which polymer chains begin 
to become entangled and is approximated by the dimensionless product of the intrinsic viscosity 
and the concentration, [η]C, which is referred to as the Berry number, Be [32].  The 
concentration at which the Berry number is approximately equal to 1 is the critical concentration 
[32].  To determine the critical concentration for our PMMA-MEK polymer-solution system, the 
intrinsic viscosity was first calculated according to the Mark-Houwink-Sakurada equation, which 
is given by [29,30] 
[ ] aKM=η         (1) 
where K and a are both constants which have been reported in literature to be 6.8x10-3 mL/g and 
0.72 respectively for PMMA solutions in MEK [30].  Using equation (1), the intrinsic viscosity 
for PMMA with a molecular weight of 996,000 g/mol was calculated to be 141.7 mL/g.  From 
this value, C* was calculated to be 0.007 g/mL by assuming a value of 1 for the Berry number.  
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Since all of our PMMA solutions have a concentration greater than 0.007 g/mL we can conclude 
that we are within the semi-dilute solution regime.       
The critical concentration can be used to predict the solution viscosity for semi-dilute 
polymer solutions where the concentration is greater than C* and is given by [32], 
)13/(3
0
*
−





=
υ
ηη
C
C
 (2) 
where η is the viscosity of the solution, ηo is the viscosity of the solvent, which is 0.426 cP for 
MEK, C is the polymer concentration (g/mL), and ν is the Flory exponent which is 0.5 for theta 
solvents and 0.6 for good solvents.  Using equation (2) we determined the viscosity of our 5, 8, 
10, and 15% PMMA solutions in MEK and plotted them as a logarithmic function of solution 
concentration, which is shown in figure 2a.  In addition, the average wall thickness was also 
plotted as a logarithmic function of the calculated solution viscosity, in figure 2b to illustrate this 
relationship. The relationship between solution viscosity and nanotube wall thickness has not yet 
been fully explored and to our knowledge our data are the first of this kind.  A systematic study 
that investigates the viscosity, molecular weight, nanopore diameter, polymer type and surface 
energy will enable us to better understand the physical mechanism contributing to the wall 
thickness, and which property the thickness is more dependent upon.  A better understanding of 
these variables will help researchers gain more control of the core-shell fabrication process 
described in this paper. 
 TEM images of PLLA-PMMA core-shell nanostructures formed using 5, 8, and 10% 
PMMA solutions are given in figure 3.  It can be seen that the light PMMA shell thickness 
directly correlates to the solution concentration, as reported in figure 2.   
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Figure 3: TEM images of PLLA-PMMA core-shell nanowires using a) 5% PMMA solution, b) 
8% PMMA solution, and c) 10% PMMA solution to form the shell layer and melt wetting at 
100oC for 2 hours to form the core layer. 
 
Melt wetting was used for filling our PMMA polymer shell with a PLLA core.  The 
wetting approach chosen for the core polymer could be either solution or melt wetting depending 
upon the properties of the core polymer.  The choice of solution wetting versus melt wetting is 
dependent upon the melting or glass transition (Tg) temperatures of the shell and core polymers 
and whether they are mutually soluble in the solvent of choice.  To fill the core via melt wetting, 
it is important that the Tg of the core polymer be lower than the shell polymer to enable an 
intermediate temperature to be chosen for the second wetting step.  Likewise, to fill the core via 
solution wetting, the core polymer should be dissolved in a non-solvent for the shell polymer to 
prevent mixing at the interface during wetting.  For our PMMA and PLLA system, we chose to 
use melt wetting because of our previous work with fabricating homogeneous PLLA nanorods 
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via melt wetting [24] and because the Tg of PLLA is about 48
oC, which is lower than PMMA, 
which is about 105oC.   
Our previous work with PLLA nanorods demonstrated that by melt wetting with a 
commercial AAO template at 100oC for 24 hours we were able to achieve homogenous PLLA 
nanowires.  We chose to use the same melt wetting temperature to fill our PMMA shells with 
PLLA because we wanted to utilize conditions that were known and had already proven to be 
successful for our previous work with homogeneous PLLA nanorods.  At a temperature within 
the range of the Tg for PMMA, we expected that there may be some mixing at the interface of the 
two polymers, especially for longer melt wetting times.  Although mixing is not desirable, it was 
more important for us to use known conditions so we could compare our heterogeneous core-
shell structures with the homogenous PLLA structures fabricated using the same conditions.  In 
addition, we chose to use two melt wetting times, 2 and 24 hrs, to observe how it would affect 
the extent to which the core was filled and the extent of mixing between the core and shell 
layers.  Our TEM results for homogenous PLLA nanorods revealed relatively short nanorods, in 
comparison to the thickness of the template, with a large distribution of lengths ranging 
anywhere from 1 – 10 µm.  Theoretically the length of the nanorods should be approximately 60 
µm, which is the thickness of the template.  The short length and large length distribution that we 
observed is a result of the sonication step used during template dissolution.  In addition the 
strong base may also be truncating the nanorods by hydrolyzing PLLA.  Based on our TEM 
study of the homogenous PLLA nanorods, we expected to see core-shell nanostructures after 24 
hr melt wetting.  We also expected to observe more mixing between the core and shell layers 
after 24 hr melt wetting in comparison with the 2 hr melt wetting.    
A mixture of two different core-shell morphologies was observed for both 2 hr and 24 hr 
melt wetting times.  TEM images of PLLA-PMMA core-shell nanostructures fabricated using 
5% PMMA solutions for solution wetting and 100oC for melt wetting are shown in figure 4.  The 
two morphologies that were observed for each wetting time can be described generally as a 
“random” morphology and a “periodic” morphology, and the random morphology was observed 
to be most prominent for both wetting times.   
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Figure 4: PLLA-PMMA core-shell nanostructure fabricated by melt wetting for 2 hrs (a) 
showing a random, segmented core morphology, (b) showing a periodic, segmented core 
morphology. PLLA-PMMA core-shell nanostructure fabricated by melt wetting for 24 hrs (c) 
showing a segmented structure with mixing between the core and shell layers, and (d) showing a 
periodic structure with mixing between the core and shell layers. 
 
The random core-shell nanostructures observed for the 2 hr wetting time contained 
several short, discontinuous segments of PLLA at locations throughout the entire length of the 
PMMA shells (figure 4a).  The dark PLLA segments inside the PMMA shell are only a few 
hundred nanometers in length, which is very short in comparison to the homogeneous PLLA 
nanowires. This result can be explained by the shorter melt wetting time.  The presence of 
multiple, discontinuous segments, may be a consequence of the difference in the interfacial 
driving force, which would be weaker between two low surface energy polymers (heterogeous 
core-shell nanostructures) than between a low surface energy polymer and a high surface energy 
ceramic, like AAO (homogenous polymer nanostructures).   
We did not anticipate the surface energy of the polymers to be a problem based on our 
previously published work where we melt wetted multilayered polymer thin films of 
poly(styrene) (PS) and PMMA to achieve core-shell structures (figure 5) [19].  By melt wetting 
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PS and PMMA simultaneously in a layered thin film we demonstrated core-shell structures with 
complete core filling.  Unfortunately the controllability of the shell thickness was not as easy to 
achieve using this melt wetting approach, which was the reason for developing the two-step 
wetting approach described in this paper.  Future work will focus on identifying the process 
variables that enabled the complete and continuous filling demonstrated in our previous work 
[19] and applying them to this new method which offer much better control of the shell 
thickness.  
 
 
Figure 5:  TEM image of PMMA/PS core-shell nanowires fabricated by melt wetting a 
multilayered PMMA and PS thin polymer film at 150oC for 48 hrs.  PS was stained dark using 
RuO4. 
 
Nanostructures with a much different “random” morphology were observed for the 
longer melt wetting time.  Figure 4c shows TEM images of nanorod segments of various lengths 
that are only weakly connected.  The nanorod segments appear to be within the same size range 
as the discontinous PLLA core segments observed for the shorter melt wetting time, however, 
the contrast between the core and shell layers is much less discernable.  These fragmented 
structures are very similar to structures reported by T. P. Russel et al, who studied structures 
resulting from Rayleigh instabilities [31].  Russel’s research demonstrated that PMMA films 
formed on the walls of nanochannels by solution wetting produced nanorods with encapsulated 
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holes when annealed at temperatures between 150oC and 200oC [31].  The encapsulated holes 
were formed as a result of the PMMA films undulating to reduce the surface area and the 
undulations eventually growing enough in amplitude to merge and leave behind holes [31].  We 
hypothesize that Rayleigh instabilities could have contributed to the fragmented structures that 
we obtained by lengthening the melt wetting time for the PLLA core filling.  Similar to Russel’s 
work with PMMA, we annealed PLLA at a temperature of 100oC, which is approximately 50oC 
higher than the Tg.  At this temperature we were also within the range of the Tg of the PMMA 
film that was originally solution wetted within the pores,  and it is likely that the PMMA 
molecules were also somewhat mobile, though not as much as the PLLA.  Under these 
conditions, it is possible that the PLLA could have started to undulate within the PMMA shell to 
reduce its surface area and, as a result of this motion, the two polymers could have mixed within 
the nanochannels.  This mixing combined with the Rayleigh instabilities could lead to the more 
homogeneous appearance at the interface of two polymers of the fragmented nanostructures 
observed in figure 4c.  Furthermore, when the template is completely removed, the 
nanostructures are no longer mechanically supported by the AAO nanochannels, and it is likely 
that the removal of the AAO template caused the collapse of the thin walls surrounding the 
nanopores formed by the Rayleigh instabilities resulting in the fragmented structures that we 
observed.  
In addition to the random morphologies that were observed for both melt wetting times, a 
small percentage of the nanostructures exhibited a very unique periodic morphology which is 
shown in figure 4b and 4d.  It was observed that the periodic morphology of the PLLA segments 
within the PMMA shell for the 2 hr melt wetting time appeared to have the same periodicity as 
the nanosegments that were observed for the 24 hr melt wetting time.  An important difference, 
which was also observed for the random morphologies, is that it the longer melt wetting time 
caused the PMMA and PLLA to mix within the nanochannel making the core and shell layers 
less discernable while the shorter melt wetting time resulted in a distinct contrast between the 
PMMA shell and PLLA core.  The formation of the periodic morphology is not completely 
understood at this time, and does not represent a significant portion of the core-shell 
nanostructures that were fabricated for either melt wetting time.  However, it may be beneficial 
to investigate what process parameters contribute to the formation of periodic structures in order 
to intentionally fabricate core-shell nanostructures with this periodicity.         
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Conclusions 
In summary, we demonstrate the feasibility of fabricating polymer core-shell nanowires 
using our two-step wetting process.  We were able control the thickness of the polymer shell by 
varying the polymer solution concentration and relate the thickness to the solution viscosity.  We 
investigated the effect of wetting time on the extent of core filling and mixing of the core and 
shell layers.  We observed that the shorter melt wetting times created many differently sized 
PLLA plugs within the PMMA shell and very discrete core and shell polymer layers.  For longer 
melt wetting times we observed many weakly connected nanorod segments and significant 
mixing between the core and shell polymer layers, both of which were likely caused by Rayleigh 
instabilities within the nanopores. Future work will focus on investigating different polymers, 
melt wetting temperatures, and melt wetting times to achieve more uniform and complete core 
filling and reduce the amount of mixing between the core and shell.  This pioneering work opens 
the arena for future studies to better understand and control the formation and properties of core-
shell polymer nanostructures using our two-step wetting process.  
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CHAPTER 4: CONCLUSIONS AND FUTURE WORK 
This thesis presents a series of papers that demonstrate the versatility of template-assisted 
nanofabrication methods and exploit the fundamental principles to realize unique, 
multifunctional nanostructure morphologies with great potential for drug delivery applications.  
This work began by exploring two potential template-assisted fabrication approaches, namely the 
layer-by-layer method to fabricate protein nanostructures and template wetting to fabricate 
polymer nanostructures.  Through literature review and our experimental trials we determined 
that template wetting was a versatile and controllable template-assisted fabrication approach. 
Using the layer-by-layer method we were able to demonstrate the fabrication of glucose 
oxidase nanocapsules by covalently bonding multiple protein layers within the nanochannels of 
AAO templates [Paper 1].  The major drawback of this method was the use of a crosslinker, 
glutaraldehyde, to bind the protein layers together. Glutaraldehyde is a known carcinogen and 
draws an immediate red flag for biomedical applications like drug delivery.  As an alternative to 
covalently binding protein layers to form protein nanostructures, we attempted to use 
electrostatic attractions to build up protein layers within AAO templates [Paper 2 and Appendix 
2].  Unfortunately, despite our extensive literature review and persistent experimental trials, we 
were only able to fabricate mechanically weak single protein, bovine serum albumin, 
nanostructures using electrostatic attractions alone and this was done with very minimal success.  
During this study, however, we revealed some questionable results published by other 
researchers regarding this fabrication method.  This evidence raises significant doubts about the 
feasibility of the layer-by-layer method to fabricate stable single protein nanostructures via 
electrostatic assembly.  By incorporating an additional protein we were able to demonstrate 
glucose oxidase/avidin protein nanotubes by electrostatic layer-by-layer assembly in conjunction 
with glutaraldehyde to bind the initial protein layer to the template.  As a result of our limited 
success fabricating protein nanostructures without the use of glutaraldehyde, we shifted the focus 
of our fabrication to polymeric materials. 
Using template wetting methods, which are based on capillary action, we were able to 
fabricate a much larger array of unique nanostructures.  Building upon the pioneering work done 
by other researchers, we were able to fabricate heterogeneous segmented nanowires by melt 
wetting with multilayered polymer films [Paper 3], and heterogeneous core-shell nanowires by 
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sequential solution wetting and melt wetting [Paper 4].  These novel fabrication techniques 
provide simple, low cost, and versatile approaches to fabricate multifunctional nanostructures.  
The demonstration of these novel template-assisted fabrication techniques opens the arena for 
future studies focused on process control, optimization, and applicability towards specific 
applications.  
The use of layer-by-layer techniques to fabricate protein nanostructures and template 
wetting to fabricate unique polymer nanostructures illustrates the versatility of template-assisted 
nanofabrication.  The demonstrated versatility, ease of fabrication, and low cost of template-
assisted nanofabrication make it a viable option for the future manufacturing of one-dimensional 
nanomaterials and optimization for a wide variety of applications including drug delivery. 
Future work should focus on utilizing and optimizing the fabrication methods that were 
demonstrated in this dissertation to design and fabricate nanostructures specifically for drug 
delivery.  The core-shell nanostructures presented in Paper 4 are expected to be the most useful 
and promising nanostructure we fabricated for use as a drug delivery device.  The first step that 
must be done before incorporating therapeutic molecules within the core of these nanostructures 
is to improve the filling of the core material to achieve more continuous core filling.  As 
discussed in Paper 4, it is likely that the filling is not continuous because of the low interfacial 
driving force between two low energy polymers.  To overcome this interfacial energy problem, 
the following potential approaches should be investigated: 
1. Chemically oxidize the inner surface of the shell polymer through mild acidic 
treatment to increase the surface energy of the shell material, and subsequently 
increase the driving force for wetting. 
2. Use a material with a higher surface energy for the shell, such as a metal or ceramic.  
Metals could be depositing within AAO templates via methods such as 
electrodeposition and ceramics could be deposited via methods such as sol gel.   
Once complete and continuous core-shell filling has been achieved, this project can move 
forward with application based experimentation which focuses on drug delivery.  This work 
should include the incorporation of therapeutic molecules within the core material, evaluation of 
the drug loading, and measurement of the drug release profiles for nanostructures with different 
diameters, lengths, and aspect ratios.  Preliminary experiments and thoughts regarding the future 
work for this project are presented in Appendix 4. 
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APPENDICES 
Appendix 1. Process used to determine average pore size and nanotube wall 
thickness using ImageJ image analysis software 
 
After opening the imageJ software, an SEM or TEM image can be dragged onto the 
ImageJ tool bar for analysis.  The first step for any type of quantitative analysis using ImageJ is 
to set the scale in according to the scale bar for the image.  This is done by drawing a line that is 
equal in length to the length of the scale bar on the image and selecting “Set Scale” from the 
Analyze menu. 
Using ImageJ to Analyze Pore Size 
 
An example of an SEM image that may be used to determine the average pore size of 
AAO templates is shown in Figure 1a.  To analyze the pore size, the image must be adjusted to 
include only black circles where the pores are.  This is done by adjusting the image’s threshold.  
The resulting threshold image is shown in Figure 1b.  Next the size of all the pores is measured 
by selecting “Analyze Particles” from the Analyze menu.  The minimum and maximum size of 
the particles can be set to avoid measuring partial pores along the edges of the SEM images.  
After analyzing the particles, ImageJ creates a drawing, shown in Figure 1c, with outlines of all 
the pores that were measured and displays a table with the number of the pores and the area of 
the pores.  Using excel, the area can be used to calculate the diameter of all the pores.  Then the 
average diameter of all the pores can be calculated with the error given by the standard deviation.  
The number of pores measured is strongly dependant upon the magnification of the SEM image.  
Higher magnification will contain fewer pores, whereas lower magnification will include more.   
 
 
 84 
Figure 1: a) SEM image of an AAO template with uniform nanopores b) Threshold image of the 
SEM image showing black circles in place of the nanopores c) Particle analysis image showing 
outlines of all the nanopores analyzed. 
 
Using ImageJ to Analyze Nanotube Wall Thickness 
 
An example of a TEM image that may be used to determine the average wall thickness of 
a set of nanotubular structures is shown in Figure 2a.  After setting the scale, lines can be drawn 
across the nanotube walls, as shown in Figure 2b, to determine the thickness of the walls.  To 
calculate the average wall thickness for a given sample of nanotubes, at least 2 different images 
of nanotubes were analyized, and the wall thickness was measured in at least 5 different areas for 
each nanotube giving an n ≥ 10.  This analysis method was used primarily to determine the effect 
of polymer solution viscosity on the average wall thickness of our polymer nanotubes. 
 
 
 
Figure 2: a.) TEM image of a polymer nanotube structure b) Magnified version of the TEM 
image that illustrates the lines drawn using ImageJ to measure the wall thickness.
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Appendix 2. Fabrication of bovine serum albumin nanotubes through 
template assisted layer by layer assembly 
 
Dawei Zhang, Shelley A. Dougherty and Jianyu Liang 
Abstract 
Protein nanotubes have been successfully fabricated via sequential filtration of bovine serum 
albumin (BSA) solution at pH 3.8 and pH 7.0 through the nanochannels of anodic aluminum 
oxide (AAO) templates. The morphology of the nanostructures has been examined using SEM 
and TEM. Also, a simple analysis from UV/Vis spectroscopy has shown that the pH values of 
the solutions in our experiment did not significantly damage the bioactivity of BSA. Our future 
work will focus on strengthening the mechanical stability of the protein nanotubes and more 
precisely controlling their morphology.    
Introduction 
Since Iijima first discovered carbon nanotubes,1 researchers worldwide have been 
enthusiastically exploring the characteristics and applications of one-dimensional nanostructures 
composed of carbon,2 ceramics,3  metals4 and polymeric materials.5 Out of all the synthetic and 
natural materials, protein based nanotubes are particularly desirable for biomedical applications 
due to their ease of functionalization and intrinsic biocompatibility. Two preparation approaches, 
namely self-assembly and template-assisted synthesis have been investigated for producing 
protein nanotubes directly. Self assembly methods have been successfully employed to fabricate 
protein nanotubes based on flagella,6,7 viral capsids,8,9 tubulin10 and Hcp1.11 However, self 
assembly methods are typically limited to the unique chemistry and functionality of the 
biomolecules. In addition, the morphologies and dimensions of the self-assembled nano-tubular 
structures are restricted by the properties of the original bulk materials. The template-assisted 
method provides a highly versatile alternative. The template-assisted processes for the 
fabrication of protein nanotubes rely upon either the chemical crosslinking of proteins, the so-
called alternate immersion method,12,13 or electrostatic charges between protein layers, the so-
called layer by layer (LbL) method.14,15  These mechanisms can be easily adapted to many 
different proteins with little to no modifications.  This advantage renders template-assisted 
methods viable for a wide range of applications.    
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The LbL assembly method has long been used in the electrostatic deposition of thin films 
on flat substrates and surfaces of particles.16-18 Multilayers composed of different charged 
species can be built up following a conventional procedure: A negatively charged solid substrate 
is alternately immersed in solutions of cationic polyelectrolyte and anionic polyelectrolyte16 to 
build up a film consisting of alternating layers of polyelectrolytes by the electrostatic interaction 
between them. It is also well established that by tuning the ionic strength and pH environment of 
the solution, the layer thickness, surface roughness and permeability of the multilayer can be 
precisely controlled.19-21  
Recently, the LbL assembly approach has been applied in anodic aluminum oxide (AAO) 
templates to demonstrate the successful fabrication of protein based nanotubes. For example, 
nanotubes of cytochrome C have been fabricated inside polyethylenimine (PEI)-pretreated AAO 
templates by the alternate adsorption of positively charged cytochrome C with negatively 
charged poly-(sodium styrenesulfonate) (PSS).14 Similarly, human serum albumin (HSA)-based 
nanotubes have been synthesized by alternating HSA with poly-L-arginine (PLA) or PEI.15 To 
date, the published works have been primarily focused on composite nanotubes of protein 
molecules and charged polymers. Only a few of these studies have attempted the fabrication of 
single component nanotubes with HSA.22,23 In this paper we have demonstrated the fabrication of 
bovine serum albumin (BSA) nanotubes using LbL deposition of protein molecules inside a 
nanoporous AAO template.   
Albumin, the most abundant plasma protein in the bloodstream, is an acidic protein with 
high solubility in water. It is very robust in extreme pH environments and organic solutions. It 
can be heated to 60 ˚C for up to 10 hours without catastrophic damage to its chemistry.24 BSA 
consists of 583 amino acids and has a molecular weight of 66 kDa.25 BSA has been successfully 
used in biological applications like HSA, but is much lower in cost since it can be readily 
purified from bovine blood. The isoelectric point (pI) of BSA is 4.7. Under pH 4.7, BSA 
molecules carry a positive charge. And above pH 4.7, BSA molecules carry a negative charge. In 
the present work, oppositely charged BSA molecules have been assembled into nanotubes inside 
the nanochannels of AAO templates in an LbL fashion. The obtained protein nanostructures have 
been characterized using scanning electron microscopy (SEM) and transmission electron 
microscopy (TEM). The effect of solution pH on BSA bioactivity has been investigated by 
UV/vis spectroscopy. 
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Experimental Part 
Materials.  AAO templates (13mm) were purchased from Whatman Co., with an inner pore 
diameter of ca. 200 nm and thickness of 60 µm. The BSA was obtained from Sigma and was 
stored at 2 ˚C before use. All the chemicals were used as received without further purification.  
Layer-by-layer Assembly.  The AAO template was sandwiched between two cellulose 
membranes (MF-Millipore) and was fixed into a stainless steel microsyringe filter (Whatman 
Co.). 9 mL of BSA in a citric-phosphate buffer solution (2 mg/mL, 10 mM) at pH 3.8 and pH 7 
were sequentially injected into the filter at a speed of 0.5 mL/min. Between each filtration step, 9 
mL of DI water was filtered through the template at a speed of 1 mL/min, followed by drying the 
template in air for 10 min. After three sequential filtration steps, the AAO template was washed 
thoroughly with DI water. The BSA aggregated on the surface of the template was carefully 
removed using Kimwipes before the template was dried overnight in the air. 
Characterization.  Nanotube morphology was characterized using SEM (JSM-7000, JEOL) and 
TEM (Philips CM 12). UV/vis spectrometer (Genesys 10UV scanning spectrophometer, Thermo 
Electron) was used to evaluate the absorbance of BSA molecules in a wide range of pH 
environments (pH 1.15~12). Zeta potential was used to measure BSA charge in the acidic and 
basic buffer solutions.  Zeta potential was measured using a ZetasizerNano (Malvern Zen3 600). 
 
Results and discussions 
BSA is a heart-shaped molecule comprised of three domains at its pI.26 However, it 
undergoes several well-recognized conformational changes under different pH conditions. 
Associated with the variation of the BSA conformation, the ionic properties of albumins are also 
dependent on pH environment. Figure 1 shows the pH dependent zeta-potentials of BSA 
solutions at a concentration of 2 mg/mL, which represents the net charge that BSA molecules 
carry. The curve agrees well with the model from the early work by Fogh-Anderson et al.27 The 
albumin’s zeta potential decreases from 25.1 mV to zero at around pH 4.7 and becomes negative 
with increasing pH. BSA solutions at pH 3.8 and 7 were chosen for the alternate filtrations based 
on literature reviews.22 Additionally, we demonstrated that the zeta potential is positive (12.3 
mV) at pH 3.8 and negative (-17.9 mV) at pH 7 which allows the electrostatic assembly of the 
adsorbed BSA layers. 
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Figure 1. pH-dependent zeta potential of BSA molecules 
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Figure 2. UV/Vis spectroscopy of BSA solution at different pH 
 
To examine the bioactivity of BSA molecules at pH 3.8 and 7, UV/Vis spectroscopy was 
performed on the same solutions that we used for LbL filtrations. As shown in Figure 2, the 
absorption curves of positively charged BSA at pH 3.8 and negatively charged BSA at pH 7 are 
overlapped with the curve obtained at its nature state (pH 4.7). It is known that without being 
irreversibly denatured, the BSA molecule is significantly adaptive to a wide range of pH values 
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by frequent expansion and contraction. The pH-dependent conformations of BSA are classified 
as N, the native form (pH 4.3-8); F, the fast-migrating form (pH 2.7-4.3) and E, the expanded 
form (pH<2.7). In a basic environment, BSA will adapt to B, the basic form (pH 8-10) and A, the 
aged form (pH>10).26,28 Albumin can recover from structural changes caused by almost any 
condition except long periods of treatment with heat and alkalinity.24 Our observation complies 
with the fact that at pH 3.8 (F form) and 7.0 (N form), BSA still maintains a relatively natural 
state, in which the molecules are not yet expanded enough to lose their original 3D 
structures.28,29   
In addition, based on our previous experience of making SEM and TEM samples, AAO 
templates can only be dissolved by strong acids or strong bases. To explore the effect of the pH 
values of different solutions used to remove the AAO on the bioactivity of BSA molecules, 
UV/Vis spectroscopy was also used on the bulk solutions (2 mg/mL) of BSA in 5% H3PO4 and 
0.01 M NaOH. For BSA in 5% H3PO4 solution, there is a slight difference in the region of 200 
nm-230 nm, but no significant deviation of the UV/Vis curve has been found. However, for BSA 
in 0.01 M NaOH solution, the typical absorbance peak at 280 nm from tryptophan and tyrosine 
residues exhibits a red shift, indicating the change in the secondary structure. Also, the far-
ultraviolet region below 240 nm splits into two peaks which is further evidence of the 
degradation of the albumin molecule caused by alkaline.30 Consequently, 5% H3PO4 was 
preferred for the etching of AAO templates in our experiment.  
In this work, positively charged BSA molecules were first adsorbed onto the anionic sites 
on the pore wall of the AAO templates at pH 3.8, followed by a quick washing of the loosely 
bound molecules and drying of the protein surface. Negatively charged BSA solution at pH 7.0 
was then filtered through the membrane. Like weak polyelectrolyte multilayers obtained on flat 
substrates, long incubation times of at least 10 min are required to ensure a sufficient charge 
interaction.31-34 This is especially important for the first layer of protein adsorbed on the alumina 
surface, which plays an important role in the successful build-up of the consecutive layers.35 In 
comparison, we have also tested filtrations of the same amount of BSA solution at a speed of 1 
mL/min and 3 mL/min, i. e. for 9min and 3min respectively. It is not evident from SEM and 
TEM characterizations that stable protein multilayers have been deposited at those fast speeds.  
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Figure 3. a) Top view of an empty AAO template; b) Cross-sectional view of an empty AAO 
template; c) Top view of BSA multilayers deposited inside AAO template. (The scale bars are a) 
1 um; b) 100 nm; c) 1 um) 
 
Figure 3-a, b show the top view and the cross section of the AAO template we used to 
fabricated BSA nanotubes. Figure 3-c is the top view of an AAO template after deposition of 
BSA multilayers inside the nanopores. It is seen that after six filtrations, the pores in the AAO 
template (Figure 3-c) are filled with protein. However, the thicknesses of the BSA multilayers 
are not uniform. This may be attributed to complex morphology of the substrates provided by 
AAO for LbL deposition. It is known from studies on LbL assemblies on planar surfaces, that the 
amount of deposited polyelectrolytes significantly depends on the surface roughness36-38 and the 
curvature39,40 of the substrate. The nanochannels in the AAO template, however, are not perfectly 
cylindrical pores with uniform diameter and are full of uneven surfaces, branches and 
discontinuities, as seen in Figure 3-a, b. These irregularities may have directly contributed to the 
inhomogeneous adsorption of BSA multilayers. 
 
Figure 4. SEM images of AAO template after etching with 5% H3PO4 for 16 hours 
a 
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(The scale bars are both 1µm) 
 
Figure 4 shows an AAO template after protein deposition that was partially etched away 
in a 5% phosphoric acid for 16 hours at 0 ˚C, in order to liberate the top portion of the protein 
nanotubes from the template. However, collapsed nanostructures were observed and individual 
protein nanotubes could not be differentiated. We hypothesize that this is because of the intrinsic 
weakness in the mechanical stability of protein nanotubes. In the early work in which LbL 
assemblies were performed on flat substrates, it has been demonstrated that the chain length of 
polyelectrolytes plays a critical part in the stability of protein multilayer. Unlike flexible 
polyions, the globular molecules of BSA are less capable of penetrating into each other to form a 
network that provides a sustainable support to the whole structure.41-44 Consequently, the BSA 
nanotubes fabricated within the AAO template, which are multilayers composed of weakly 
attracted globular protein molecules, may have an inherent disadvantage in maintaining its 
structural integrity. Additionally, at both pH 3.8 and pH 7.0, electrolytic groups on BSA 
molecules are only partially ionized. Therefore the charge provided by the coiled molecules of 
protein is limited for the electrostatic interaction between protein layers. As the aluminum oxide 
is being etched away, mechanical support gradually disappears and the soft and thin walls of the 
protein nanotubes cannot stand on their own, resulting in a structure of collapsed bundles. On the 
other hand, the acidic post-treatment of the protein multilayer in H3PO4 during the preparation of 
SEM samples may protonate many of the carboxylate groups within the protein layers. It may 
interfere with the electrostatic crosslink and mobilizes the protein chains to a certain extent, 
therefore further weakens the structural stability of the protein nanotubes.45 
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Figure 5. TEM images of BSA nanotube.  The scale bars are 200 nm (left) and 100 nm (right). 
 
To study the morphology of individual BSA nanotubes, TEM samples were prepared by 
completely dissolving the AAO template containing protein multilayers in a 5% phosphoric acid 
solution at 0 ˚C for 24 hours. It is seen that although the harsh environment that is necessary to 
etch away the alumina can compromise the stability of the protein multilayers, it is still possible 
to observe the tubular protein structure even after acidic treatment for as long as 24 hours. The 
walls of the obtained nanotubes are wavy due to the intrinsic softness of protein multilayers. 
Careful examination of the thickness of the protein nanotube walls using the image processing 
software imageJ reveals that the average wall thickness (measured in 15 different places) is 19 
nm±1.5 nm, i.e. an average of 3 nm for the deposition of each single BSA layer. This is in 
agreement with the size of BSA molecules (140 A×40 A) in its unfolded form.46 Some Y-shaped 
protein nanostructures are also seen from TEM characterization (See Figure 6), which replicates 
the branched channels in AAO templates well. This demonstrates the versatility of template-
assisted method using AAO templates as scaffold. 
a 
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Figure 6. TEM image of a Y-shaped BSA nanotube.  The scale bar is 200nm. 
 
Conclusion 
In conclusion, we have deposited single component BSA multilayers onto the nano-
channels within AAO templates via the electrostatic interaction between oppositely charged 
protein molecules. A simple analysis from UV/Vis spectroscopy in both near and far ultraviolet 
region has demonstrated that the pH of the solutions we used will not cause irreversible 
denaturation to the BSA molecules. The obtained protein nanotubes were shown by SEM to have 
collapsed into bundles due to the intrinsic mechanical weakness of protein multilayers and the 
acidic post-treatment. After the AAO template has been completely etched away, the 
morphology of the liberated protein nanotubes was characterized using TEM.  Our future work 
will focus on reinforcing the mechanical stability of our BSA nanotubes. We will also investigate 
various filtration conditions and AAO template dimensions, to enable us to precisely control the 
nanotube morphology.  
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ABSTRACT 
Heterogeneous, one-dimensional (1D) nanomaterials, such as nanorods and nanowires, 
have been utilized for a variety of different biomedical applications because they offer a unique 
combination of properties and provide a material platform for integrating multiple functions.  In 
this paper, we propose a template-assisted wetting approach to fabricate segmented polymer 
nanorods using biodegradable polymers for controlled drug delivery.  Our previous work with 
polystyrene (PS) and poly(methyl methacrylate) (PMMA) heterogeneous, segmented nanorods is 
described briefly to introduce our current preliminary work with the fabrication of homogeneous 
biodegradable nanorods and drug release from polymer thin films.  Since the template-assisted 
fabrication approach provides us unprecedented control over the size, spacing, and length of the 
heterogeneous polymer nanorods, this technique will provide for the opportunity to evaluate drug 
release kinetics as a function of the segment spacing, size of the nanorods, and aspect ratio in the 
future.  
INTRODUCTION 
Heterogeneous, one-dimensional (1D) nanomaterials, such as nanorods and nanowires, 
show great potential for a variety of different applications because they offer a unique 
combination of properties [1] and provide a material platform for integrating multiple functions 
[1].  Multifunctional 1D polymeric nanomaterials are commonly fabricated using a co-
electrospinning process [1-4] to produce core-shell polymer nanorods.  Biomedical applications 
for these structures include biosensing [1,3], drug and gene delivery [1-4], and tissue engineering 
[1,2,4]. 
1D polymer nanostructures show the greatest potential for drug delivery applications 
because of some very recent discoveries regarding particle shape and cellular uptake [5-7].  
Studies have shown that wormlike, filamentous nanoparticles are able to avoid the body’s natural 
immune response, allowing them longer circulation than spherical particles [5-7].  It is 
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hypothesized that macrophages, the cells that are responsible for engulfing foreign particles in a 
process known as phagocytosis, have difficultly stretching and adjusting their shape to engulf 
filamentous particles and exhibit significantly reduced phagocytosis than spherical particles 
[5,8].  Geng et al[7] have demonstrated that paclitaxel loaded filomicelles can circulate up to ten 
times longer, and provide the same therapeutic effect as spherical micelles with an eightfold 
smaller paclitaxel dosage per injection.  These results show great potential and have created a 
great need for low cost, simple, and versatile nanofabrication techniques to produce 1D polymer 
nanostructures for drug and gene delivery applications. 
 Template wetting is a template-assisted nanofabrication approach that is low cost, simple, 
and highly versatile [2,9].  Template wetting utilizes the nanochannels of nanoporous materials, 
such as anodized aluminum oxide (AAO) or polycarbonate, to form 1D nanostructures [2,9]. 
Template wetting offers unprecedented control over the diameter, length, and morphology of 
polymer nanostructures and it can accommodate practically all types of polymeric materials.  
Template wetting utilizes either a polymer solution or a polymer melt to achieve nanotube or 
nanorod morphologies.  By varying the polymer solution concentration nanotube wall thickness 
can be controlled, and by varying the temperature of the polymer melt, both nanorod and 
nanotube morphologies can be formed [10].  Overall, template wetting is an approach that allows 
for a multitude of different nanostructure variations.         
 Previously we were able to demonstrate the fabrication of 1D heterogeneous, segmented 
nanorods by template-assisted wetting with an alternating thin film of polystyrene (PS) and 
poly(methyl methacrylate) (PMMA) [11].  PS and PMMA were used as model polymers to 
optimize the template wetting conditions for segmented nanorod fabrication.  This paper 
describes our preliminary work with the fabrication and characterization of biodegradable 
poly(e-caprolactone) (PCL) and poly(L-lactic acid) (PLLA) homogeneous nanorods and drug 
release profiles for ibuprofen from PLLA thin films.  This preliminary work presents the means 
to which the fabrication of heterogeneous nanostructures and the characterization of drug release 
from these nanostructures can ultimately be attained.   
EXPERIMENTAL 
Materials 
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PLLA (Mw: 100,000 – 150,000 g/mol, Tg: 48.6 
oC) and PCL (Mw: 70,000 – 90,000 
g/mol, Tm: 60 
oC) were purchased from Sigma Aldrich and used as received.  Anodisc 13 
commercial AAO templates with average pore diameter of 200 nm were purchased from 
Whatman and used as received. 
Nanostructure fabrication 
Thin films of PLLA were cast from chloroform solutions containing ~1 wt% PLLA and 
0.05%, 0.1% and 0.2% ibuprofen and allowed to dry in air for several days.  These solutions 
yielded films that should theoretically contain approximately 5%, 10%, and 20% ibuprofen 
respectively.  Films were cut into squares approximately 1 cm2.  A hot plate set to 80 oC and 100 
oC was used for PCL and PLLA wetting respectively.  The polymer film was place on top of 
either a homemade AAO template with 50 nm diameter pores or commercial AAO template with 
200 nm diameter pores and placed on the hot plate for approximately 24 hours.  The homemade 
AAO templates were fabricated using a 2 step anodization process which is described in other 
works [12].  After wetting, the AAO template was dissolved in a 0.01 M NaOH solution for 
approximately 24 hours, ultrasonicated for 30 minutes, and finally the nanostructures were 
collected by vacuum filtration using a 50 nm diameter polycarbonate filter.  Nanostructure 
morphology was characterized using TEM. 
Drug release from polymer thin films 
Thin films of PLLA were cast from solution as described previously. Films were cut into 
squares approximately 1 cm2 and the mass of each film was measured using an analytical 
balance.  The total mass of the thin film was used to calculate the total amount of drug in the thin 
film based on the ratio of drug and polymer in the solution.  The thickness of the films was 
measured at four points using a caliper with precision up to 0.001 mm to insure uniform 
thickness.   
To determine whether the ibuprofen was fully dissolved in the PLLA and to verify the 
concentration of ibuprofen in the PLLA films, DSC was used to measure the change in the 
melting temperature as a result of the ibuprofen.  This is based upon the principle of freezing 
point depression; when a solute, in this case the ibuprofen, is dissolved in a pure solvent, in this 
case PLLA, the freezing/melting point of the solvent decreases as a function of the solute 
concentration.  The depression of the melting point is given by the following equation:  
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∆T = Km      (1) 
where ∆T is the change in melting temperature, m is the molality of the solution, and K is the 
cryoscopic constant which is given by,  
K =
RTm
2M
∆H f
      (2) 
where R is the gas law constant, Tm is the melting temperature of the pure solvent, M is the 
molar mass of the pure solvent, and ∆Hf is the enthalpy of fusion of the pure solvent.  ∆Hf can be 
taken from the DSC data as the area under the melting curve for pure PLLA. 
 PLLA thin films were immersed in 0.01 M phosphate buffer solution (PBS) and 
incubated at 37oC.  After certain time intervals, 1 mL aliquots of the PBS was removed, and the 
absorbance at 224 nm and 266 nm were measured using UV-vis spectroscopy.  A set of standard 
ibuprofen solutions with concentrations ranging from 0.57 mg/L to 570 mg/L were used to 
generate standard curves relating ibuprofen concentration to absorbance for both 224 nm and 266 
nm.  It was determined that the standard curve for 224 nm is most accurate for measuring 
concentrations less than 22 mg/L and 266 nm is the most accurate for measuring concentrations 
greater than 22 mg/L.  The ibuprofen standard curves are shown in Figure 1.  
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Figure 1. Standard curve for absorbance as a function of ibuprofen concentration in PBS 
measured by UV-vis spectroscopy at 224 nm and 266 nm 
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The diffusion coefficients for each drug concentration were calculated based upon two equations 
that provide an early-time approximation [13], from 0% - 60% drug release, which is given by,  
M t
Mo
= 4
Dt
πl2
 
 
 
 
 
 
1
2
     (3) 
and a late-time approximation [13], from 40% - 100% drug release, which is given by, 
   
M t
Mo
=1−
8
π 2
exp
−π 2Dt
l2
 
 
 
 
 
     (4) 
where Mt is the mass of drug at time t, Mo is the mass of total drug in the film, D is the diffusion 
coefficient, and l is the thickness of the thin film. 
RESULTS AND DISCUSSION  
Biodegradable nanostructure morphology 
Biodegradable nanorods were fabricated from PCL and PLLA polymers using a 
template-assisted wetting approach.  One of the major drawbacks of this nanofabrication 
approach, specifically for biodegradable materials, is that a harsh acidic or basic solution is 
required to dissolve the AAO template to liberate the nanorods.  Treatment of the AAO 
templates with strong acids and bases as well as the increased surface area of the liberated 
nanostructures make it essential to verify that the nanostructures do not completely dissolve 
during the fabrication process.  TEM images of PCL and PLLA nanorods, given in Figure 2, 
show that our nanorods are not completely dissolved during the process.   
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Figure 2. TEM images of a.) PCL nanorod from homemade AAO template with 50 nm diameter 
pores, b.) PCL nanorod from commercial AAO template with 200 nm diameter pores, and c.) 
PLLA nanorod from commercial AAO template with 200 nm diameter pores 
 
The TEM images of the PCL nanorods formed both in homemade and commercial AAO 
templates show that the diameter of the nanorods agrees well with the diameter of the template 
nanopores, 50 nm and 200 nm respectively.  From this we can conclude that the NaOH used to 
dissolve the AAO templates had little effect on the nanostructure.  The TEM image of the PLLA 
nanorods formed in the commercial AAO template, however, shows that the diameter of the 
nanorod is only about 125 nm, which is less than the expected 200 nm diameter of the nanopore.  
This result suggests that the PLLA nanorods did dissolve slightly during the fabrication process.  
It is likely that the PCL nanorods were less susceptible to hydrolytic degradation than PLLA 
because PCL is more hydrophobic and slightly more crystalline causing the diffusion of the 
NaOH solution to be slower.  This needs to be further investigated if PLLA nanorods are to be 
used in the future for drug delivery.   
The length of the nanorods varies significantly from a few hundred nanometers up to a 
few microns.  Theoretically the nanorods could be as long as 60 µm, which is the thickness of 
the template.  This wide length distribution is expected.  When the template is removed the 
nanostructures are sonicated to disperse them and this process causes them to fragment into 
much shorter lengths.  In addition, the wide length distribution may also be caused by hydrolytic 
erosion from the ends of the nanorods. 
Polymer dissolution during the nanofabrication process will have a substantial impact on 
the drug release kinetics.  Future work will include efforts towards the fabrication of 
heterogeneous segmented and/or core-shell biodegradable nanorods for drug release 
experiments. 
Drug release from PLLA thin films  
In order to understand and interpret drug release data for nanostructures, preliminary 
work with polymer thin films has been done.  Thin films of PLLA with 5%, 10%, and 20% 
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ibuprofen were fabricated and the release of ibuprofen from the films was measured with UV-vis 
spectroscopy as a function of time.   
To confirm that ibuprofen was dissolved in the PLLA and not present as crystals, the 
melting temperature of PLLA was measured for each thin film using DSC.  The measured 
melting temperature for each polymer film is given in Table I. 
Table I. Percentage of ibuprofen dissolved in PLLA/Ibuprofen thin films based upon the 
depression of the melting point measured by DSC 
Theoretical % 
Ibuprofen 
Melting Temp (
o
C) ∆T 
Calculated % 
Ibuprofen from 
DSC 
0 173.6 - - 
5 169.2 4.3 2.9 
10 164.4 9.1 5.7 
20 160.4 13.2 7.8 
 
This data show that the melting point of PLLA decreases with increasing amounts of ibuprofen. 
Using the change in the melting point from the DSC data, the concentration of ibuprofen actually 
dissolved in the polymer films was calculated from equations (1) and (2) and is also given in 
Table I. 
The concentration of ibuprofen dissolved in the PLLA films calculated from the DSC 
data is considerably less than the concentration of ibuprofen that should have been in the films 
based upon the composition of the solutions that the thin films were cast from.  No pure 
ibuprofen peaks were found on the DSC curves for any of the thin films.  This result leads to the 
conclusion that the as cast films were not uniform and homogenous. This conclusion is further 
supported by the visual appearance of the films.  Some regions of the thin films looked as though 
they were spotted, which is likely caused by drug crystals.  The DSC samples and films used for 
drug release were taken from regions of the polymer films that visually appeared to be 
homogenous.  This could present a problem during nanorod fabrication.  Having inhomogeneous 
regions of drug along the nanorod could cause the rods to loose some mechanical stability.  The 
solubility of ibuprofen in biodegradable polymers is currently being investigated so that an 
appropriate, homogenous system can be chosen for future drug-loaded nanorod fabrication and 
drug release studies. 
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The percent ibuprofen released from the PLLA films as a function of time is given in 
Figure 3.  The polymer film with the highest concentration of ibuprofen had the most rapid drug 
release and the polymer film with the lowest concentration of ibuprofen had the slowest drug 
release.  This trend was expected because the higher ibuprofen concentration gives the largest 
concentration gradient, which leads to the fastest diffusion.   
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Figure 3.  Percent ibuprofen release from PLLA thin films as a function of ibuprofen 
concentration and time 
 
An early-time approximation and a late-time approximation of the diffusion coefficient for each 
ibuprofen concentration were calculated using equations (3) and (4).  The average thin film 
thickness was measured to be 0.018±0.009 mm.  This value was used for the diffusion 
coefficient calculations which are given in Table 2. 
Table II. Early-time and late-time approximations of the diffusion coefficient D of ibuprofen in 
PLLA thin films 
Ibuprofen D (m
2
/s) Early D (m
2
/s) Late 
5% 6.0 x 10-13 1.0 x 10-17 
10% 22 x 10-13 1.8 x 10-17 
20% 500 x 10-13 5.7 x 10-17 
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The early-time approximations of the diffusion coefficients are an order of magnitude different 
in value, showing a large difference in the initial driving force for diffusion.  A similar study that 
measured the release of ibuprofen from poly(ε-caprolactone-c-D,L-lactide) also reported the 
trend of increasing diffusion coefficient with increasing initial drug concentration [13].  
However, the increase in diffusion coefficient was not as significant as our results, and ranged 
from 2.5x10-13 m2/s at 5% ibuprofen to 6.5x10-13 m2/s at 20% ibuprofen [13].  This difference in 
magnitude for the higher ibuprofen concentration may be a result of the inhomogeneous nature 
of the ibuprofen dissolved and dispersed in the PLLA films that we observed.  Once most of the 
drug has diffused from the polymer film, the diffusion coefficients are much less dependent upon 
the initial drug loading, which also agrees with previous studies [13].  This preliminary work 
with thin films will facilitate the interpretation and modeling of future drug release data for 
biodegradable nanorods. 
CONCLUSIONS 
This paper demonstrates the fabrication of biodegradable nanorods using a template-
assisted wetting approach.  The nanorods were fabricated from both PCL and PLLA using both 
homemade AAO templates with 50 nm pore diameters and commercial AAO templates with 200 
nm pore diameters and their structure was characterized with TEM.  In addition, this paper  
describes preliminary drug release data for ibuprofen release from PLLA thin films.  Future work 
will include the incorporation of ibuprofen within biodegradable nanorods and will utilize the 
preliminary thin film drug release data to interpret and model the drug release behavior of the 
nanorods. 
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Appendix 4. Preliminary Data for Drug Release from Nanoporous Alumina 
Membranes 
Abstract 
 The use of nanoporous materials as controlled drug delivery devices is highly desirable.  
Researchers have demonstrated that solute molecules diffusing from nanochannels which are 
only slightly larger than the molecular dimensions of the solute yield diffusion profiles which 
deviate from traditional Fickian diffusion and have the potential to yield zero-order release 
profiles.  The diffusion profiles for nanochannels are typically lower than predicted by Fickian 
diffusion and have been defined as hindered diffusion, where the solute diffusivity is a function 
of the ratio between the solute radius and the nanochannel radius.  Despite the many empirical 
and theoretical relationships that have been developed to describe hindered diffusion as a 
function of the nanochannal radius, few studies have considered other dimensions of the 
nanochannels such as the length and aspect ratio.  In this study we measure the release of 
ibuprofen diffusing from 200, 50, and 20 nm diameter nanochannels with lengths of 60, 40, and 
20 µm respectively.  Although conclusions could not be drawn from our limited preliminary 
data, we are able to offer many considerations that should be taken into account for future drug 
release experiments.    
Introduction 
The transport of solute molecules from nanoporous materials is of great interest for 
applications such as ultrafiltration [1], chromatographic and eletrophoretic separations [1], 
heterogeneous catalysis [1], and controlled drug delivery [1,2].  For example, the use of 
nanoporous coatings on implantable devices such as drug-eluting stents has shown promising 
results and is a highly desirable alternative for controlled release without the use of polymers [3-
5].   
Obtaining “zero-order” drug delivery, where the same amount of drug is release per unit 
time for extended periods of time, is a highly sought after goal for controlled drug delivery 
devices.  Ferrari’s research group has obtained zero-order release for many molecules from 
nanochannels and has observed that these release profiles can not be explained by Fick’s laws 
[6].  They reasoned that Fick’s laws are based upon the assumption that solute molecules 
experience Brownian motion in three-dimensions and in nanochannels, where motion is confined 
to one-dimension, this assumption is not met [6].  Essentially, if the diameter of a nanochannel is 
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within the same order of magnitude of a drug molecule, the diffusivity of the drug molecules in 
the nanochannel will be hindered [1,7,8].  The hindered diffusion of the solute is thought to be 
caused by both a thermodynamic phenomenon and a transport effect [8].  Thermodynamically, 
the interaction between the solute and the pore wall causes the solute to be excluded from the 
region near the pore wall causing an intrapore concentration driving force which is less than the 
bulk solution concentration driving force [1,8].  The transport effect is caused by the 
hydrodynamic drag that is experienced by the solute molecule, which is higher than the drag 
experience by the solute in bulk fluids [1,8].  The combination of these two effects has led to the 
definition of an effective diffusion coefficient to describe hindered diffusion in nanopores.  The 
effective diffusion coefficient is a function of the ratio between the solute particle radius and the 
nanopore radius which is given by [1,8],  
        
pore
solute
r
r
=λ            (1) 
Research to understand the   of hindered diffusion extends back as early as the 1950’s and has 
generated several phenomen ological models to relate the effective diffusion coefficient to λ.  
One such empirical relationship was developed by Renkin [1,8] and is given by, 
    ( ) ( )532 948.0089.2104.211 λλλλ −+−−= ∞DD          (2)  
where D is the effective diffusion coefficient and D∞ is the bulk diffusion coefficient.  Renkin’s 
equation is valid for situations where spherical, non-interacting particles are moving along the 
center of a pore [1].  For spherical solutes the bulk diffusion coefficient is given by the Stokes-
Einstein equation,  
    
soluter
Tk
D
πµ
β
6
=∞             (3) 
Where kβ is Boltzmann’s constant, T is absolute temperature, and µ is the solvent viscosity.  
 In this study we investigate release of ibuprofen from cylindrical nanochannels with 200, 
50, and 20 nm diameters and lengths of 60, 40, and 20 µm respectively.  Ibuprofen is a well 
known anti-inflammatory drug [9] which has a very small size (radius of approximately 5 nm) 
[9,10], and has very low solubility in water (< 1 mg/mL).  Ibuprofen was used as our model drug 
because it is commonly employed as a model drug for controlled release studies [9] and we used 
it previously for measuring the release from polymer thin films to characterize the diffusion 
coefficient [11].  After measuring the release of ibuprofen from the nanochannels of AAO, we 
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planned to measure the release of ibuprofen from nanochannels of AAO filled with a 
polymer/ibuprofen mixture.  Therefore, it would be used for comparison and enable conclusions 
to be drawn with regard to thin film geometry versus a cylindrical nanochannel.     
Experimental 
Materials 
Ibuprofen was purchased from Sigma Aldrich and used as received.  AAO templates with ~ 200 
nm average pore diameter and 60 um thick were purchased from Whatman and used as received.  
AAO templates with ~ 50 nm average pore diameter and 40 um thick and ~20 nm average pore 
diameter and 20 um thick were fabricated using a two-step anodization process described 
elsewhere [12]. 
Loading AAO templates with drug 
Ibuprofen was melted on a hot plate at approximately 40oC.  Once the ibuprofen was completely 
liquid, an AAO template was placed on top of the liquid, and the liquid ibuprofen was allowed to 
enter the nanochannels via capillary action.  The surfaces of the AAO templates were washed 
with DI water and carefully wiped to remove as much ibuprofen from the surface as possible.  
The mass of the AAO template was measured with an analytical balance before and after the 
drug loading to determine the total amount of drug loaded into the nanochannels. 
In vitro release tests 
The release tests were conducted at room temperature in vitro.  Each test sample was placed in 
capped vials (20 mL) with 5 mL DI water.  At predetermined time intervals, the vials were 
carefully shaken and 1 mL of the solution was removed for analysis.  UV-vis spectroscopy was 
used to determine the amount of ibuprofen in the DI water.  The absorbance was measured at 224 
nm and 266 nm using a Genesys UV-vis spectrometer.  Standard curves were used to correlate 
the absorbance to the concentration of ibuprofen, to calculate the mass of ibuprofen released 
from the AAO templates [11].  After measuring the absorbance, the DI water was returned to the 
sample vial. 
Results and Discussion 
The release profiles for ibuprofen diffusing from AAO templates with 200, 50, and 20 nm 
diameters and lengths of 60, 40, and 20 µm respectively were measured using UV-vis 
spectroscopy.  A standard curve of ibuprofen concentration as a function of absorption was used 
to calculate the mass of ibuprofen released from the templates.  The ibuprofen was initially 
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loaded into the templates by melt wetting and the mass of ibuprofen loaded into each template 
was calculated by weighing the templates before and after the wetting process.  The percentage 
of the ibuprofen that was released from the template at a given time was calculated by dividing 
the mass released at that time by the initial mass of ibuprofen loaded into the template.  The 
release profiles of ibuprofen from the three nanochannels are shown in figure 1. 
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Figure 1:  Release profiles for ibuprofen diffusing from nanochannels with 200, 50, and 20 nm 
diameters and lengths of 60, 40, and 20 µm respectively. 
 
 
It was observed that the slowest drug release profile was obtained for the 200 nm diameter, 60 
µm long nanochannel and the fastest for the 20 nm diameter, 20 µm long nanochannel.  This 
result demonstrates that the drug release profile is strongly dependent upon the length of the 
nanochannels, which is an obvious result based upon the theory of diffusion.  From our results it 
appears that the diameter of the nanochannels had little to no effect on the drug release profile.  
This result was further supported by calculating the diffusion coefficient for ibuprofen in water 
using equation (3) and plotting the effective diffusion coefficient, which was calculated using 
equation (1) and (2), as a function of the nanochannel diameter.  The diffusion coefficient for 
ibuprofen in water was calculated to be 4.36x10-10 m2/s and figure 2 shows the effective 
diffusion coefficient as a function of the nanochannel diameter.    
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Figure 2: Graph that shows the effective diffusion coefficient as a function of the nanochannel 
diameter 
 
From figure 2 it can be seen that the effective diffusion coefficients for the nanochannel 
diameters used in this study are not significantly different.  It appears that nanochannels would 
need to be 10 nm in diameter or less to see the effects of hindered diffusion and the one-
dimensional confinement of a drug molecule with a radius of 0.5 nm.  Based on this information, 
we can conclude that we either needed to use nanochannels with smaller diameters or use a 
larger model drug to draw any conclusions regarding the effects of hindered diffusion and 
nanoconfinement.  
 Another observation about the data presented in figure 1 is that 100% drug release was 
not obtained for any of the nanochannel dimensions within our timeframe and the release profiles 
began to plateau at values that were inversely proportional to the length of the nanochannels.  
From our results we have shown that approximately 10%, 35%, and 75% total mass is released 
from the 60, 40, and 20 µm long nanochannels respectively when the profiles begin to plateau.  
This result may be the result of two different issues associated with the design of this 
experiment.  First, in our experimental procedure we measured the absorbance of 1 mL of 
solution then returned the solution to our sample vial.  By doing this, the concentration of solute 
in the sample vial continuously increases with time, which also reduces the driving force for 
diffusion.  Additionally, the driving force would be reduced at a different rate for each of the 
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samples.  This may explain the plateau we observed and also prevents us from drawing any 
conclusions because the data may not be comparable.  The experimental procedure for future 
drug release experiments should include the replacement of the measured samples with fresh 
solution so that sink conditions are maintained.  Second, we do not know whether the ibuprofen 
filling was uniform and complete for the three different nanochannel lengths and diameters 
because the templates were not all the same size.  In the future, if templates with the same 
surface area are used, we can calculate the theoretical upper limit for the total amount of drug in 
each template based on the porosity, nanochannel diameter, and thickness of the templates if we 
assume all the nanochannels are uniformly and completely filled.  This calculation combined 
with the weight gain of the template would allow us to estimate how full the nanochannels are, 
which will be very useful information for interpreting our results.  Since we do not know the 
extent to which our nanochannels are filled with ibuprofen, we also cannot draw any conclusions 
from these data.   
Conclusions 
 In summary, this study reported the drug release of ibuprofen from three different 
nanoporous AAO templates, each with a different thickness and nanochannel diameter.  We were 
unable to draw any conclusions with respect to hindered diffusion and nanoconfinement because 
of several flaws associated with the design of this experiment.  These flaws included lack of 
consideration of the size of ibuprofen with respect to the size of our nanochannels, not 
maintaining sink conditions in the bulk solution, and inability to estimate the extent to which the 
nanochannels were initially filled with ibuprofen.  In addition, ibuprofen may not have been the 
most appropriate model drug choice because of its low water solubility and small size.  Future 
drug release studies will take these issues into consideration so that meaningful conclusions can 
be drawn about the effects of hindered diffusion and nanoconfinement.     
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